THIOPHENE BASED APYRASE INHIBITORS

20260116872 ยท 2026-04-30

    Inventors

    Cpc classification

    International classification

    Abstract

    Disclosed herein are apyrase inhibitors of Formula (I):

    ##STR00001##

    Also disclosed herein are methods for using the disclosed inhibitors, including in methods for protecting crops from pests. In one aspect the apyrase inhibitors are useful for enhancing the activity of pesticides for the protection of crops from pathogens and to support crop yield.

    Claims

    1. A method for inhibiting apyrase, comprising contacting the apyrase with a compound of the formula ##STR00230## or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; X is (CR.sup.aR.sup.b).sub.nY; Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently R.sup.b or R.sup.d; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; provided that the compound is not ##STR00231##

    2. The method of claim 1, wherein the compound has the formula: ##STR00232##

    3. The method of claim 1, wherein the compound has the formula: ##STR00233##

    4. The method of claim 1, wherein Z.sup.1, Z.sup.2, or both are hydrogen.

    5. The method of claim 1, wherein Z.sup.1, Z.sup.2, or both are C.sub.1-6 alkyl.

    6. The method of claim 1, wherein Z.sup.1 together with Z.sup.2 forms a 6-membered ring.

    7. The method of claim 6, wherein Z.sup.1 and Z.sup.2 together form an aliphatic ring.

    8. The method of claim 6, wherein Z.sup.1 and Z.sup.2 together form a heteroaliphatic ring.

    9. The method of claim 6, wherein Z.sup.1 and Z.sup.2 together form an aromatic ring.

    10. The method of claim 6, wherein Z.sup.1 and Z.sup.2 together form a heteroaromatic ring.

    11. The method of claim 1, wherein Z.sup.1 together with Z.sup.2 forms a ring selected from: ##STR00234##

    12. The method of claim 1, wherein the compound has the formula: ##STR00235## ##STR00236##

    13. The method of claim 12 wherein Y is selected from the group consisting of ##STR00237## ##STR00238## ##STR00239## ##STR00240## ##STR00241## ##STR00242## ##STR00243## ##STR00244##

    14. The method of claim 1, wherein the compound is selected from the group consisting of: ethyl 2-(3-(N-(3-chlorophenyl)sulfamoyl)benzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl pyrazine-2-carboxylate 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl picolinate ethyl 2-(2-(phenylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(cyclohexyl(methyl)amino)acetamido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethylisonicotinate 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(o-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(tert-butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((4-hydroxy-6-oxo-1-propyl-1,6-dihydropyrimidin-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(1H-pyrazol-1-yl)nicotinate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate isopropyl 2-(2-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(quinolin-8-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-methoxyphenoxy)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((4-oxo-4-(thiophen-2-yl)butanoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(tert-butyl)-1,2,3,4-tetrahydroacridine-9-carboxylate ethyl 2-(2-cyclopentylacetamido)-4,5-dimethylthiophene-3-carboxylate isopropyl 2-(2-((5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-fluorophenoxy)acetamido)thiophene-3-carboxylate ethyl 2-(2-(thieno[2,3-d]pyrimidin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-phenylacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(2-((methylsulfonyl)methyl)-1H-benzo[d]imidazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(benzo[d]oxazol-2-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((4-(2-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((3-(4-methyl-2-oxothiazol-3(2H)-yl)propanoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(3-bromoisonicotinamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((5-amino-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(naphthalen-2-yloxy)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((1-(3-fluorophenyl)cyclopentane-1-carbonyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(6,7-dimethoxy-4-oxoquinazolin-3(4H)-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(5-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)furan-2-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((4-amino-5-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 6-methyl-2-(5-methylpyrazine-2-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((4-fluorophenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 6,6-dimethyl-2-(2-(methylsulfonyl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(methyl(phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-(1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate isopropyl 2-(1-methyl-1H-1,2,3-triazole-5-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-(4-oxopyrazolo[1,5-d][1,2,4]triazin-5(4H)-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-ethoxyacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(phenylthio)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((4-methoxybenzyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt of isopropyl 2-(2-((3-hydroxypropyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylisoxazole-4-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate isopropyl 2-(2-((4-allyl-5-methyl-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((2-methoxyphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((5-methyl-1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-(3-cyanophenoxy)acetamido)thiophene-3-carboxylate ethyl 2-(2-((5-amino-1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(3-(phenylthio)propanamido)thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5-methylpyrazine-2-carboxylate ethyl 2-(2-((1,3,4-thiadiazol-2-yl)thio)acetamido)thiophene-3-carboxylate ethyl 2-(2-(quinazolin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(1-acetylpyrrolidine-3-carboxamido)-6,6-dimethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2,5-dimethylfuran-3-carboxylate oxalic acid salt of isopropyl 2-(2-(4-methylpiperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-oxo-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(4-(furan-2-carbonyl)piperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt of isopropyl 2-(2-(ethylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(thiophen-2-yl)acetamido)thiophene-3-carboxylate isopropyl 2-(2-(2-(4-oxo-3,4-dihydrophthalazin-1-yl)acetoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(1H-1,2,4-triazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(naphthalen-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(p-tolylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(adamantan-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((5-amino-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate isopropyl 6-methyl-2-(2-(4-(4-nitrophenyl)piperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl isonicotinate 1-(2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl)cyclopentane-1-carboxylic acid ethyl 2-(2-((1-methyl-1H-tetrazol-5-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-hydroxyquinoline-4-carboxylate ethyl 2-(2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(3-morpholinopropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 4-((2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethoxy)carbonyl)pyridine 1-oxide ethyl 2-(3-(pyrrolidin-1-yl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate ethyl 2-(2-(1-methyl-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl)acetamido)thiophene-3-carboxylate ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-acetamido-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-cyanoacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(m-tolylamino)acetamido)thiophene-3-carboxylate ethyl 2-(4-methoxy-4-oxobutanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl pyrazine-2-carboxylate ethyl 2-(2-(cycloheptylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((3,5-dimethylphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((2,6-difluorobenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(o-tolyloxy)acetamido)thiophene-3-carboxylate 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(allylamino)thiazole-4-carboxylate 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl picolinate ethyl 2-(2-(benzoyloxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((4-(methoxycarbonyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(benzylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((1-methyl-4,5-dihydro-1H-imidazol-2-yl)thio)acetamido)thiophene-3-carboxylate ethyl 2-(2-(azepan-1-yl)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((4-chlorobenzyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5-dimethylthiophene-3-carboxylate oxalic acid salt of ethyl 2-(2-(butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((3-(trifluoromethyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(2,6-dimethylmorpholino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)-N-methylacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid methyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)-2-methylpropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((4-fluorophenyl)(methyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((4-fluorophenyl)sulfonyl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(3-(4-fluorophenyl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-nitrophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(p-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-methoxyphenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(2-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-chloro-4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(benzo[d][1,3]dioxol-5-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-(trifluoromethoxy)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-(trifluoromethyl)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyridin-4-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyridin-3-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((tetrahydro-2H-pyran-4-yl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)benzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-5-methyl-4-oxo-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate 6,6-dioxide ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]pyran-3-carboxylate ethyl 2-(2-phenoxyacetamido)benzo[b]thiophene-3-carboxylate ethyl 5-methyl-4-oxo-2-(2-phenoxyacetamido)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]thiopyran-3-carboxylate 5,5-dioxide ethyl 2-(2-((2-methylbenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(N-methylpyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate; and ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate, or a combination thereof.

    15. The method of claim 1, wherein contacting the apyrase comprises treating a crop with the compound.

    16. The method of claim 15, further comprising treating the crop with a pesticide.

    17. The method of claim 19, wherein the pesticide comprises a fungicide.

    18. A composition, comprising a fungicide; a compound of the formula ##STR00245## or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; X is (CR.sup.aR.sup.b).sub.nY; Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)]&OR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently R.sup.b or R.sup.d; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; and a phytologically acceptable carrier.

    19. The composition of claim 18, wherein the composition comprises from about 1 to about 80 weight percent of the compound.

    20. A pesticidal composition, comprising a pesticide; a compound of the formula ##STR00246## or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; X is (CR.sup.aR.sup.b).sub.nY; Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently R.sup.b or R.sup.d; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; and a phytologically acceptable carrier.

    Description

    DETAILED DESCRIPTION

    I. Terms

    [0008] The following explanations of terms and methods are provided to better describe the present disclosure and to guide those of ordinary skill in the art in the practice of the present disclosure. The singular forms a, an, and the refer to one or more than one, unless the context clearly dictates otherwise. The term or refers to a single element of stated alternative elements or a combination of two or more elements, unless the context clearly indicates otherwise. As used herein, comprises means includes. Thus, comprising A or B, means including A, B, or A and B, without excluding additional elements. All references, including patents and patent applications cited herein, are incorporated by reference in their entirety, unless otherwise specified.

    [0009] Unless otherwise indicated, all numbers expressing quantities of components, molecular weights, percentages, temperatures, times, and so forth, as used in the specification or claims, are to be understood as being modified by the term about. Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that may depend on the desired properties sought and/or limits of detection under standard test conditions/methods. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word about is expressly recited.

    [0010] Unless explained otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described below. The materials, methods, and examples are illustrative only and not intended to be limiting.

    [0011] Administering refers to any suitable mode of administration, to control a fungal pathogen, including, treatment of an extant crop, seeds, soil or combination thereof.

    [0012] Control with reference to a fungal pathogen, means block, inhibit and/or eradicate a fungal pathogen and/or prevent the fungal pathogen from damaging a crop. In one embodiment, control refers to the reduction of one or more fungi to undetectable levels, or to the reduction or suppression of a fungus to acceptable levels as determined by one of ordinary skill in the art (for example, a crop grower). Determinations of acceptable levels of fungus reduction are based on a number of factors, including to the crop, pathogen, severity of the pathogen, use restrictions, economic thresholds and other factors known to those of ordinary skill in the art.

    [0013] As used herein, the terms enhancer and potentiator, refer to a compound or compounds disclosed herein that enhance the effects of a pesticide. Without limitation to theory the present enhancer compounds disclosed herein may function by blocking one or more pathways by which a pathogen, such as a fungal pathogen, evades toxicity, such as by detoxifying, sequestering or transporting a pesticide. In certain embodiment, the present compounds inhibit enzymatic apyrase activity which leads to the enhancement, accentuation or potentiation of a pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and/or nematocide. For example, when the enhancer or potentiator is used in conjunction with a fungicide, the combination of the potentiator and the fungicide enhances the fungicidal effect of the fungicide and/or renders a fungus that has become resistant to the fungicide susceptible to the fungicide as a result of the activity of the potentiator. Most often, these enhancers or potentiators do not themselves inhibit the growth of a fungus itself, nor do they have a detrimental effect on a living organism that is (or could be) infected with a fungus.

    [0014] As used herein, the term inoculation refers to a method used to administer or apply an effective amount of a disclosed compound or formulation thereof to a target area of a field and/or plant. The inoculation method can be, but is not limited to, aerosol spray, pressure spray, direct watering, and dipping. Target areas of a plant could include, but are not limited to, the leaves, roots, stems, buds, flowers, fruit, seed of the plant, and bulbs of the plant including bulb, corm, rhizoma, stem tuber, root tuber and rhizophore. Inoculation can include a method wherein a plant is treated in one area (for example, the root zone or foliage) and another area of the plant becomes protected (for example, foliage is inoculated when a disclosed compound is applied in the root zone or new growth when applied to foliage).

    [0015] As used herein, the terms wettable granule, water dispersible granule, and dispersible granule refer to a solid granular formulation prepared by a granulation process, optionally containing fine particles of polymer-associated active ingredient, or aggregates of the same, a wetting agent and/or a dispersant, and optionally an inert filler. Wettable granules can be stored as a formulation, and can be provided to the market and/or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, wettable granules are prepared for application by the end user. The wettable granules are mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, target pathogen, time of year, geography, local regulations, and intensity of infection or pathogen load among other factors. Once properly diluted, the solution can be applied by spraying.

    [0016] As used herein, the terms wettable powder, water dispersible powder, and dispersible powder, refer to a solid powdered formulation that contains active ingredient, optionally associated with a polymer, or aggregates of the same, and optionally one or more of a dispersant, a wetting agent, and an inert filler. Wettable powders can be stored as a formulation, and can be provided to the market and/or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, a wettable powder is prepared for application by the end user. The wettable powder is mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of fungal load, among other factors. Once properly diluted, the solution can be applied by spraying.

    [0017] As used herein, the term high solids liquid suspension refers to a liquid formulation that contains fine particles of active ingredient, or fine polymer particles associated with active ingredient, or aggregates of the same, a wetting agent and/or a dispersant, an anti-freezing agent, optionally an anti-settling agent or thickener, optionally a preservative, and water or oil as a carrier. High solids liquid suspensions can be stored as a formulation, and can be provided to the market and/or end user without further processing. In practical application, high solids liquid suspensions are prepared for application by the end user. The high solids liquid suspensions are mixed with water or oil in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of infection among other factors. Once properly diluted, the solution can be applied by spraying.

    [0018] As used herein, the term phytologically acceptable refers to compositions, diluents, excipients, and/or carriers that are generally applicable for use with any part of a plant during any part of its life cycle, including but not limited to seeds, seedlings, plant cells, plants, or flowers. The compositions can be prepared according to procedures, methods and formulas that are known to those of skill in the agricultural arts. Following the teachings of the present disclosure the artist skilled in the agricultural and/or chemical arts can readily prepare a desired composition. Most commonly, the compounds disclosed herein can be formulated to be stored, and/or applied, as aqueous or non-aqueous suspensions or emulsions prepared neat or from concentrated formulations of the compositions. Alternatively the compounds disclosed herein can be formulated for use in aerosol-generating equipment for application to agricultural produce stored in sealed chambersan application method known as fogging. Water-soluble, water-suspendable or emulsifiable formulations comprising the presently disclosed compounds can also be converted into or formulated as solids (for example, wettable powders), which can then be diluted into a final formulation. In certain formulations, the compositions of the present disclosure can also be provided in growth media, such as in vitro media for growth of plant or other types of cells, in laboratory plant growth media, in soil, or for spraying on seeds, seedlings, roots, stems, stalks, leaves, flowers or the entire plant.

    [0019] Compounds herein can include all stereoisomers, including E and Z isomers, enantiomers, diastereomers, mixtures, racemates, atropisomers, and tautomers of the illustrated structures.

    [0020] Non-limiting examples of optional substituents include hydroxyl groups, sulfhydryl groups, halogens, amino groups, nitro groups, nitroso groups, cyano groups, azido groups, sulfoxide groups, sulfone groups, sulfonamide groups, carboxyl groups, carboxaldehyde groups, imine groups, alkyl groups, halo-alkyl groups, alkenyl groups, haloalkenyl groups, alkynyl groups, halo-alkynyl groups, alkoxy groups, aryl groups, aryloxy groups, aralkyl groups, arylalkoxy groups, heterocyclylalkyl groups, heteroaryl groups, cycloalkyl groups, acyl groups, acyloxy groups, carbamate groups, amide groups, ureido groups, epoxy groups, and ester groups.

    [0021] Alkyl refers to an optionally substituted straight-chain, or optionally substituted branched-chain saturated hydrocarbon. Non-limiting examples of alkyl groups include straight, branched, and cyclic alkyl and alkylene groups. An alkyl group can be, for example, a C.sub.1, C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45, C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. In some cases alkyl refers to a group having from one to about ten carbon atoms, or from one to six carbon atoms, wherein an sp.sup.3-hybridized carbon of the alkyl residue is attached to the rest of the molecule by a single bond. Whenever it appears herein, a numerical range such as C.sub.1-6 alkyl means that the alkyl group consists of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term alkyl where no numerical range is designated. In some embodiments, the alkyl is a C.sub.1-10 alkyl, a C.sub.1-9 alkyl, a C.sub.1-8 alkyl, a C.sub.1-7 alkyl, a C.sub.1-6 alkyl, a C.sub.1-5 alkyl, a C.sub.1-4 alkyl, a C.sub.1-3 alkyl, a C.sub.1-2 alkyl, or a C.sub.1 alkyl.

    [0022] Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, 2-methyl-1-propyl, 2-methyl-2-propyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-3-butyl, 2,2-dimethyl-1-propyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2,2-dimethyl-1-butyl, 3,3-dimethyl-1-butyl, 2-ethyl-1-butyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, tert-amyl, and hexyl, and longer alkyl groups, such as heptyl, octyl, and the like.

    [0023] Non-limiting examples of straight alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl.

    [0024] Branched alkyl groups include any straight alkyl group substituted with any number of alkyl groups. Non-limiting examples of branched alkyl groups include isopropyl, isobutyl, sec-butyl, and t-butyl.

    [0025] When a carbon number limit is given at the beginning of a term which itself comprises two terms, the carbon number limitation is understood as inclusive for both terms. For example, for the term C.sub.7-14arylalkyl, both the aryl and the alkyl portions of the term are included the carbon count, a maximum of 14 in this example, but additional substituent groups thereon are not included in the atom count unless they incorporate a carbon from the group's designated carbon count, as in the oxo example above. Likewise when an atom number limit is given, for example 6-14 membered heteroarylalkyl, both the heteroaryl and the alkyl portion are included the atom count limitation, but additional substituent groups thereon are not included in the atom count unless they incorporate a carbon from the group's designated carbon count. As an example, the alkyl portion of, e.g. C.sub.7-14arylalkyl is meant to include alkylene, alkylidene or alkylidyne, unless stated otherwise, e.g. as in the terms C.sub.7-14arylalkylene or C.sub.6-10aryl-CH.sub.2CH.sub.2.

    [0026] Unless stated otherwise specifically in the specification, an alkyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, the alkyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, the alkyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkyl is optionally substituted with halogen. Non-limiting examples of substituted alkyl groups includes hydroxymethyl, chloromethyl, trifluoromethyl, aminomethyl, 1-chloroethyl, 2-hydroxyethyl, 1,2-difluoroethyl, and 3-carboxypropyl.

    [0027] Alkenyl refers to an optionally substituted straight-chain, or optionally substituted branched-chain hydrocarbon having one or more carbon-carbon double-bonds. The olefin or olefins of an alkenyl group can be, for example, E, Z, cis, trans, terminal, or exo-methylene. An alkenyl group can be, for example, a C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45, C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. Non-limiting examples of alkenyl and alkenylene groups include ethenyl, prop-1-en-1-yl, isopropenyl, but-1-en-4-yl; 2-chloroethenyl, 4-hydroxybuten-1-yl, 7-hydroxy-7-methyloct-4-en-2-yl, and 7-hydroxy-7-methyloct-3,5-dien-2-yl.

    [0028] Whenever it appears herein, a numerical range such as C.sub.2-C.sub.6 alkenyl means that the alkenyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term alkenyl where no numerical range is designated. In some embodiments, the alkenyl is a C.sub.2-C.sub.10 alkenyl, a C.sub.2-C.sub.9 alkenyl, a C.sub.2-C.sub.8 alkenyl, a C.sub.2-C.sub.7 alkenyl, a C.sub.2-C.sub.6 alkenyl, a C.sub.2-C.sub.5 alkenyl, a C.sub.2-C.sub.4 alkenyl, a C.sub.2-C.sub.3 alkenyl, or a C.sub.2 alkenyl. Unless stated otherwise specifically in the specification, an alkenyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkenyl is optionally substituted with halogen.

    [0029] Alkylene refers to straight, branched and cyclic (and combinations thereof) divalent radical consisting solely of carbon and hydrogen atoms, containing no unsaturation and having from one to ten carbon atoms, for example, methylene, ethylene, propylene, n-butylene and the like. Alkylene refers to to the same residues as alkyl, but having two points of attachment and, specifically, being fully saturated. Examples of alkylene include ethylene (CH.sub.2CH.sub.2), propylene (CH.sub.2CH.sub.2CH.sub.2), dimethylpropylene (CH.sub.2C(CH.sub.3).sub.2CH.sub.2), cyclohexan-1,4-diyl and the like. The term alkylidene and alkylidyne refer to straight, branched and cyclic (and combinations thereof) divalent radicals consisting solely of carbon and hydrogen atoms, and having at least one alkene or alkyne bond, respectively.

    [0030] Alkynyl refers to an optionally substituted straight-chain or optionally substituted branched-chain hydrocarbon. The triple bond of an alkynyl group can be internal or terminal. An alkynyl or alkynylene group can be, for example, a C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45, C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. Non-limiting examples of alkynyl groups include ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, and 2-methyl-hex-4-yn-1-yl; 5-hydroxy-5-methylhex-3-yn-1-yl, 6-hydroxy-6-methylhept-3-yn-2-yl, and 5-hydroxy-5-ethylhept-3-yn-1-yl.

    [0031] Whenever it appears herein, a numerical range such as C.sub.2-C.sub.6 alkynyl means that the alkynyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term alkynyl where no numerical range is designated. In some embodiments, the alkynyl is a C.sub.2-C.sub.10 alkynyl, a C.sub.2-C.sub.9 alkynyl, a C.sub.2-C.sub.8 alkynyl, a C.sub.2-C.sub.7 alkynyl, a C.sub.2-C.sub.6 alkynyl, a C.sub.2-C.sub.5 alkynyl, a C.sub.2-C.sub.4 alkynyl, a C.sub.2-C.sub.3 alkynyl, or a C.sub.2 alkynyl. Unless stated otherwise specifically in the specification, an alkynyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkynyl is optionally substituted with halogen.

    [0032] A haloalkyl group can be any alkyl group substituted with any number of halogen atoms, for example, fluorine, chlorine, bromine, and iodine atoms. A halo-alkenyl group can be any alkenyl group substituted with any number of halogen atoms. A haloalkynyl group can be any alkynyl group substituted with any number of halogen atoms.

    [0033] An alkoxy group can be, for example, an oxygen atom substituted with any alkyl, alkenyl, or alkynyl group. An ether or an ether group comprises an alkoxy group. Non-limiting examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, and isobutoxy.

    [0034] The term acyl refers to the groups HC(O), alkyl-C(O), cycloalkyl-C(O), cycloalkenyl-C(O), aryl-C(O), heteroaryl-C(O) and heterocyclyl-C(O) where alkyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocyclyl are as described herein. By way of example acyl groups include acetyl and benzoyl groups.

    [0035] Alkoxy refers to a radical of the formula OR.sup.a where R.sup.a is an alkyl radical as defined. Unless stated otherwise specifically in the specification, an alkoxy group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkoxy is optionally substituted with halogen.

    [0036] Aminoalkyl refers to an alkyl radical, as defined above, that is substituted by one or more amines. In some embodiments, the alkyl is substituted with one amine. In some embodiments, the alkyl is substituted with one, two, or three amines. Hydroxyalkyl include, for example, aminomethyl, aminoethyl, aminopropyl, aminobutyl, or aminopentyl. In some embodiments, the hydroxyalkyl is aminomethyl.

    [0037] Aryl refers to a radical derived from a hydrocarbon ring system comprising hydrogen, 6 to 30 carbon atoms, and at least one aromatic ring. The aryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the aryl is bonded through an aromatic ring atom) or bridged ring systems. In some embodiments, the aryl is a 6- to 10-membered aryl. In some embodiments, the aryl is a 6-membered aryl. Aryl radicals include, but are not limited to, aryl radicals derived from the hydrocarbon ring systems of anthrylene, naphthylene, phenanthrylene, anthracene, azulene, benzene, chrysene, fluoranthene, fluorene, as-indacene, s-indacene, indane, indene, naphthalene, phenalene, phenanthrene, pleiadene, pyrene, and triphenylene. In some embodiments, the aryl is phenyl. Unless stated otherwise specifically in the specification, an aryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the aryl is optionally substituted with halogen.

    [0038] Arylalkyl or Aralkyl refers to a residue in which an aryl moiety is attached to a parent structure via one of an alkylene, alkylidene, or alkylidyne radical. Examples include benzyl, phenethyl, phenylvinyl, phenylallyl and the like. When specified as optionally substituted, both the aryl, and the corresponding alkylene, alkylidene, or alkylidyne portion of an arylalkyl group can be optionally substituted. By way of example, C.sub.7-11arylalkyl refers to an arylalkyl limited to a total of eleven carbons, e.g., a phenylethyl, a phenylvinyl, a phenylpentyl and a naphthylmethyl are all examples of a C.sub.7-11arylalkyl group.

    [0039] Cycloalkyl refers to a stable, partially or fully saturated, monocyclic or polycyclic carbocyclic ring, which may include fused (when fused with an aryl or a heteroaryl ring, the cycloalkyl is bonded through a non-aromatic ring atom), bridged, or spiro ring systems. Representative cycloalkyls include, but are not limited to, cycloalkyls having from three to fifteen carbon atoms (C.sub.3-C.sub.15 cycloalkyl), from three to ten carbon atoms (C.sub.3-C.sub.10 cycloalkyl), from three to eight carbon atoms (C.sub.3-C.sub.8 cycloalkyl), from three to six carbon atoms (C.sub.3-C.sub.6 cycloalkyl), from three to five carbon atoms (C.sub.3-C.sub.5 cycloalkyl), or three to four carbon atoms (C.sub.3-C.sub.4 cycloalkyl). In some embodiments, the cycloalkyl is a 3- to 6-membered cycloalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered cycloalkyl. Non-limiting examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl groups. Cycloalkyl groups also include fused-, bridged-, and spiro-bicycles and higher fused-, bridged-, and spiro-systems. A cycloalkyl group can be substituted with any number of straight, branched, or cyclic alkyl groups. Non-limiting examples of cyclic alkyl groups include cyclopropyl, 2-methyl-cycloprop-1-yl, cycloprop-2-en-1-yl, cyclobutyl, 2,3-dihydroxycyclobut-1-yl, cyclobut-2-en-1-yl, cyclopentyl, cyclopent-2-en-1-yl, cyclopenta-2,4-dien-1-yl, cyclohexyl, cyclohex-2-en-1-yl, cycloheptyl, cyclooctanyl, 2,5-dimethylcyclopent-1-yl, 3,5-dichlorocyclohex-1-yl, 4-hydroxycyclohex-1-yl, 3,3,5-trimethylcyclohex-1-yl, octahydropentalenyl, octahydro-1H-indenyl, 3a,4,5,6,7,7a-hexahydro-3H-inden-4-yl, decahydroazulenyl, bicyclo-[2.1.1]hexanyl, bicyclo[2.2.1]heptanyl, bicyclo[3.1.1]heptanyl, 1,3-dimethyl[2.2.1]heptan-2-yl, bicyclo[2.2.2]octanyl, and bicyclo[3.3.3]undecanyl. Monocyclic cycloalkyls include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.

    [0040] Polycyclic cycloalkyls or carbocycles include, for example, adamantyl, norbornyl, decalinyl, bicyclo[3.3.0]octane, bicyclo[4.3.0]nonane, cis-decalin, trans-decalin, bicyclo[2.1.1]hexane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, and bicyclo[3.3.2]decane, and 7,7-dimethyl-bicyclo[2.2.1]heptanyl.

    [0041] Partially saturated cycloalkyls include, for example, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. Unless stated otherwise specifically in the specification, a cycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the cycloalkyl is optionally substituted with halogen.

    [0042] Deuteroalkyl refers to an alkyl radical, as defined above, that is substituted by one or more deuteriums. In some embodiments, the alkyl is substituted with one deuterium. In some embodiments, the alkyl is substituted with one, two, or three deuteriums. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six deuteriums. Deuteroalkyl include, for example, CD.sub.3, CH.sub.2D, CHD.sub.2, CH.sub.2CD.sub.3, CD.sub.2CD.sub.3, CHDCD.sub.3, CH.sub.2CH.sub.2D, or CH.sub.2CHD.sub.2. In some embodiments, the deuteroalkyl is CD.sub.3.

    [0043] Haloalkyl refers to an alkyl radical, as defined above, that is substituted by one or more halogens. In some embodiments, the alkyl is substituted with one, two, or three halogens. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six halogens. Haloalkyl include, for example, trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 1,2-difluoroethyl, 3-bromo-2-fluoropropyl, 1,2-dibromoethyl, and the like. In some embodiments, the haloalkyl is trifluoromethyl.

    [0044] Halo or halogen refers to bromo, chloro, fluoro, or iodo. In some embodiments, halogen is fluoro or chloro. In some embodiments, halogen is fluoro.

    [0045] Heteroalkyl refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g., NH, N(alkyl)-), sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C.sub.1-6 heteroalkyl wherein the heteroalkyl is comprised of 1 to 6 carbon atoms and one or more atoms other than carbon, e.g., oxygen, nitrogen (e.g. NH, N(alkyl)-), sulfur, or combinations thereof wherein the heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. Examples of such heteroalkyl are, for example, CH.sub.2OCH.sub.3, CH.sub.2CH.sub.2OCH.sub.3, CH.sub.2CH.sub.2OCH.sub.2CH.sub.2OCH.sub.3, or CH(CH.sub.3)OCH.sub.3. Unless stated otherwise specifically in the specification, a heteroalkyl is optionally substituted for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.

    [0046] Hydroxyalkyl refers to an alkyl radical, as defined above, that is substituted by one or more hydroxyls. In some embodiments, the alkyl is substituted with one hydroxyl. In some embodiments, the alkyl is substituted with one, two, or three hydroxyls. Hydroxyalkyl include, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, or hydroxypentyl. In some embodiments, the hydroxyalkyl is hydroxymethyl.

    [0047] A heterocycle can be any ring containing a ring atom that is not carbon, for example, N, O, S, P, Si, B, or any other heteroatom. A heterocycle can be substituted with any number of substituents, for example, alkyl groups and halogen atoms. A heterocycle can be aromatic (heteroaryl) or non-aromatic. Non-limiting examples of heterocycles include pyrrole, pyrrolidine, pyridine, pyrimidine, pyrazine, pyridazine, piperidine, succinimide, maleimide, morpholine, imidazole, thiophene, furan, tetrahydrofuran, pyran, and tetrahydropyran.

    [0048] Heterocyclyl refers to a stable 3- to 24-membered heterocycle. Non-limiting examples of heterocycles include: heterocyclic units having a single ring containing one or more heteroatoms, non-limiting examples of which include, diazirinyl, aziridinyl, azetidinyl, pyrazolidinyl, imidazolidinyl, oxazolidinyl, isoxazolinyl, thiazolidinyl, isothiazolinyl, oxathiazolidinonyl, oxazolidinonyl, hydantoinyl, tetrahydrofuranyl, pyrrolidinyl, morpholinyl, piperazinyl, piperidinyl, dihydropyranyl, tetrahydropyranyl, piperidin-2-onyl, 2,3,4,5-tetrahydro-1H-azepinyl, 2,3-dihydro-1H-indole, and 1,2,3,4-tetrahydroquinoline; and ii) heterocyclic units having 2 or more rings one of which is a heterocyclic ring, non-limiting examples of which include hexahydro-1H-pyrrolizinyl, 3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazolyl, 3a,4,5,6,7,7a-hexahydro-1H-indolyl, 1,2,3,4-tetrahydroquinolinyl, and decahydro-1H-cycloocta[b]pyrrolyl.

    [0049] Heterocyclylalkyl refers to a heterocyclyl group that is partially or fully saturated. Accordingly, heterocyclylalkyl refers to a stable 3- to 24-membered partially or fully saturated ring radical comprising 2 to 23 carbon atoms and from one to 8 heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur. Unless stated otherwise specifically in the specification, the heterocyclylalkyl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with an aryl or a heteroaryl ring, the heterocyclylalkyl is bonded through a non-aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heterocyclylalkyl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized.

    [0050] Representative heterocyclylalkyls include, but are not limited to, heterocyclylalkyls having from two to fifteen carbon atoms (C.sub.2-C.sub.15 heterocyclylalkyl), from two to ten carbon atoms (C.sub.2-C.sub.10 heterocyclylalkyl), from two to eight carbon atoms (C.sub.2-C.sub.8 heterocyclylalkyl), from two to six carbon atoms (C.sub.2-C.sub.6 heterocyclylalkyl), from two to five carbon atoms (C.sub.2-C.sub.5 heterocyclylalkyl), or two to four carbon atoms (C.sub.2-C.sub.4 heterocyclylalkyl). In some embodiments, the heterocyclylalkyl is a 3- to 6-membered heterocyclylalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered heterocyclylalkyl. Examples of such heterocyclylalkyl radicals include, but are not limited to, aziridinyl, azetidinyl, dioxolanyl, thienyl[1,3]dithianyl, decahydroisoquinolyl, imidazolinyl, imidazolidinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperazinyl, 2-oxopiperidinyl, 2-oxopyrrolidinyl, oxazolidinyl, piperidinyl, piperazinyl, 4-piperidonyl, pyrrolidinyl, pyrazolidinyl, quinuclidinyl, thiazolidinyl, tetrahydrofuryl, trithianyl, tetrahydropyranyl, thiomorpholinyl, thiamorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxo-thiomorpholinyl, 1,3-dihydroisobenzofuran-1-yl, 3-oxo-1,3-dihydroisobenzofuran-1-yl, methyl-2-oxo-1,3-dioxol-4-yl, and 2-oxo-1,3-dioxol-4-yl. The term heterocyclylalkyl also includes all ring forms of the carbohydrates, including but not limited to, the monosaccharides, the disaccharides, and the oligosaccharides. It is understood that when referring to the number of carbon atoms in a heterocyclylalkyl, the number of carbon atoms in the heterocyclylalkyl is not the same as the total number of atoms (including the heteroatoms) that make up the heterocyclylalkyl (i.e. skeletal atoms of the heterocyclylalkyl ring). Unless stated otherwise specifically in the specification, a heterocyclylalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heterocyclylalkyl is optionally substituted with halogen.

    [0051] Heteroaryl refers to a 5- to 14-membered ring system radical comprising hydrogen atoms, one to thirteen carbon atoms, one to six heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur, and at least one aromatic ring. The heteroaryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the heteroaryl is bonded through an aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heteroaryl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized. In some embodiments, the heteroaryl is a 5- to 10-membered heteroaryl. In some embodiments, the heteroaryl is a 5- to 6-membered heteroaryl. Examples include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzothiazolyl, benzindolyl, benzodioxolyl, benzofuranyl, benzooxazolyl, benzothiazolyl, benzothiadiazolyl, benzo[b][1,4]dioxepinyl, 1,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzotriazolyl, benzo[4,6]imidazo[1,2-a]pyridinyl, carbazolyl, cinnolinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, naphthyridinyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 1-oxidopyridinyl, 1-oxidopyrimidinyl, 1-oxidopyrazinyl, 1-oxidopyridazinyl, 1-phenyl-1H-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxalinyl, quinolinyl, quinuclidinyl, isoquinolinyl, tetrahydroquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl (i.e., thienyl). Unless stated otherwise specifically in the specification, a heteroaryl is optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heteroaryl is optionally substituted with halogen.

    II. Compounds

    [0052] In one embodiment enhancers of pesticidal activity disclosed herein include those having the Formulas set forth below. In one embodiment, the present disclosure provides a method for inhibiting apyrase, comprising contacting the apyrase with a compound of Formula (I)

    ##STR00003## [0053] or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein [0054] Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; [0055] wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; [0056] R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; [0057] R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; [0058] X is (CR.sup.aR.sup.b).sub.nY; [0059] Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; [0060] R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; [0061] each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; [0062] R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, NR.sup.d, NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0063] each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; [0064] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0065] each R.sup.e is independently R.sup.b or R.sup.d; [0066] each m is independently an integer from 0 to 2; and [0067] each n is independently an integer from 0 to 2; provided that the compound is not

    ##STR00004##

    [0068] In one embodiment of compounds according to Formula (I), R.sup.1 and R.sup.2 independently are selected from hydrogen and C.sub.1-6 alkyl. In certain embodiments, R.sup.1 is C.sub.1-6 alkyl optionally substituted with one or more R.sup.a. In one embodiment of such compounds according to Formula (I) R.sup.2 is hydrogen. In another embodiment of such compounds according to Formula (I) R.sup.1 is C.sub.1-6 alkyl optionally substituted with one or more R.sup.a and R.sup.2 is hydrogen.

    [0069] In one embodiment of the enhancer compounds according to Formula (I), the compound has the formula:

    ##STR00005##

    [0070] In another embodiment of the enhancer compounds according to Formula (I), the compound has the formula:

    ##STR00006##

    [0071] In certain embodiments of enhancer compounds according to Formulas (I), (Ia) and (Ib) at least one of Z.sup.1 and Z.sup.2 is hydrogen, such as wherein Z.sup.1 is hydrogen, Z.sup.2 is hydrogen, or both Z.sup.1 and Z.sup.2 are hydrogen. In one embodiment, at least one of Z.sup.1 and Z.sup.2 is C.sub.1-6 alkyl, such as wherein Z.sup.1 is C.sub.1-6 alkyl, Z.sup.2 is C.sub.1-6 alkyl, or both Z.sup.1 and Z.sup.2 are the same or different C.sub.1-6 alkyl.

    [0072] In other embodiments of enhancer compounds according to Formulas (I), (Ia) and (Ib), Z.sup.1 and Z.sup.2 together form a 5- or 6-membered aliphatic, aromatic, heteroaliphatic or heteroaromatic ring optionally substituted with one or more R.sup.8. In one embodiment, Z.sup.1 and Z.sup.2 together form a 5- or 6-membered aliphatic or heteroaliphatic ring. In certain embodiments, Z.sup.1 and Z.sup.2 together form an aliphatic ring, and in one such embodiment, enhancer compounds of Formula (I) have Formula (Ia1):

    ##STR00007##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0073] In other embodiments wherein Z.sup.1 and Z.sup.2 together form an aliphatic ring, enhancer compounds of Formula (I) have Formula (Ib1):

    ##STR00008##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0074] In other embodiments of compounds according to Formula (I), Z.sup.1 and Z.sup.2 together form a 5- or 6-membered aromatic or heteroaromatic ring. In one embodiment, Z.sup.1 and Z.sup.2 together form an aromatic ring, and in a particular embodiment, such compounds according to Formula (I) are represented by Formula (Ia2):

    ##STR00009##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0075] In other embodiments wherein Z.sup.1 and Z.sup.2 together form an aromatic ring, enhancer compounds of Formula (I) have Formula (Ib2):

    ##STR00010##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0076] In other embodiments of compounds according to Formula (I), Z.sup.1 and Z.sup.2 together form a 5- or 6-membered heteroaromatic ring. In one embodiment, Z.sup.1 and Z.sup.2 together form a 6-membered heteroaromatic ring, and in a particular embodiment, such compounds according to Formula (I) are represented by Formula (Ia3):

    ##STR00011##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0077] In other embodiments wherein Z.sup.1 and Z.sup.2 together form a heteroaromatic ring, enhancer compounds of Formula (I) have Formula (Ib2):

    ##STR00012##

    wherein R.sup.1, R.sup.2 and X are as set forth above with respect to Formula (I).

    [0078] In one embodiment, Z.sup.1 and Z.sup.2 together form a 5- or 6-membered heteroaliphatic ring. In certain embodiments, Z.sup.1 and Z.sup.2 together form a six-membered heteroaliphatic ring, and in certain such embodiments, enhancer compounds of Formula I have a Formula (Ia4) (Ia5) or (Ia6):

    ##STR00013##

    wherein R.sup.1, R.sup.2, X and R.sup.e are as set forth above with respect to Formula (I).

    [0079] In other embodiments wherein Z.sup.1 and Z.sup.2 together form a heteroaliphatic ring, enhancer compounds of Formula (I) have Formula (Ib4), (Ib5) or (Ib6):

    ##STR00014##

    wherein R.sup.1, R.sup.2, X and R.sup.e are as set forth above with respect to Formula (I).

    [0080] In one embodiment wherein Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring, the ring is substituted with one or more of R.sup.a and R.sup.b. Certain examples of such substituted rings include compounds having Formulas (Ia7) and (Ib7):

    ##STR00015##

    wherein R.sup.1, R.sup.2, X and R.sup.e are as set forth above with respect to Formula (I).

    [0081] In certain embodiments of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), X is (CR.sup.aR.sup.b).sub.nY, wherein Ra, Rb, and X are as set forth with respect to Formula (I), and Y is selected from the group consisting of:

    ##STR00016## ##STR00017## ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023##

    [0082] Specific examples of apyrase inhibitors according to the present disclosure, including compounds of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), for use to enhance the activity of an agricultural or horticultural pesticide as described herein, are illustrated below in Table 1:

    TABLE-US-00001 TABLE 1 ID Structure Name I-1 [00024]embedded image ethyl 2-(3-(N-(3-chlorophenyl)sulfamoyl)benzamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-2 [00025]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethyl pyrazine-2-carboxylate I-3 [00026]embedded image 2-((3-(ethoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl picolinate I-4 [00027]embedded image ethyl 2-(2-(phenylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-5 [00028]embedded image ethyl 2-(2-(cyclohexyl(methyl)amino)acetamido)-5,6- dihydro-4H-cyclopenta[b]thiophene-3-carboxylate I-6 [00029]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethylisonicotinate I-7 [00030]embedded image 2-((3-(ethoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate I-8 [00031]embedded image ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-9 [00032]embedded image ethyl 2-(2-(o-tolyloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-10 [00033]embedded image ethyl 2-(2-(tert-butylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-11 [00034]embedded image isopropyl 2-(2-((4-hydroxy-6-oxo-1-propyl-1,6- dihydropyrimidin-2-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-12 [00035]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2- (1H-pyrazol-1-yl)nicotinate I-13 [00036]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate I-14 [00037]embedded image isopropyl 2-(2-(3,5-dimethyl-4-nitro-1H-pyrazol-1- yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-15 [00038]embedded image ethyl 2-(2-(quinolin-8-yloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-16 [00039]embedded image ethyl 2-(2-(4-methoxyphenoxy)acetamido)thiophene- 3-carboxylate I-17 [00040]embedded image isopropyl 2-(2-((4-oxo-4-(thiophen-2- yl)butanoyl)oxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-18 [00041]embedded image isopropyl 2-(2-((5-oxo-4-propyl-4,5-dihydro-1H-1,2,4- triazol-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-19 [00042]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2- (tert-butyl)-1,2,3,4-tetrahydroacridine-9-carboxylate I-20 [00043]embedded image ethyl 2-(2-cyclopentylacetamido)-4,5- dimethylthiophene-3-carboxylate I-21 [00044]embedded image isopropyl 2-(2-((5,7-dimethyl-[1,2,4]triazolo[4,3- a]pyrimidin-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-22 [00045]embedded image ethyl 2-(2-(3-fluorophenoxy)acetamido)thiophene-3- carboxylate I-23 [00046]embedded image ethyl 2-(2-(thieno[2,3-d]pyrimidin-4- ylthio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-24 [00047]embedded image ethyl 2-(2-phenylacetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-25 [00048]embedded image isopropyl 2-(2-(2-((methylsulfonyl)methyl)-1H- benzo[d]imidazol-1-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-26 [00049]embedded image ethyl 2-(2-(benzo[d]oxazol-2-ylthio)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-27 [00050]embedded image isopropyl 2-(2-((4-(2-methoxyphenyl)-4H-1,2,4- triazol-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-28 [00051]embedded image isopropyl 2-(2-((3-(4-methyl-2-oxothiazol-3(2H)- yl)propanoyl)oxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-29 [00052]embedded image tert-butyl 2-(3-bromoisonicotinamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-30 [00053]embedded image isopropyl 2-(2-((5-amino-4H-1,2,4-triazol-3- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-31 [00054]embedded image ethyl 2-(2-(naphthalen-2-yloxy)acetamido)thiophene- 3-carboxylate I-32 [00055]embedded image isopropyl 2-(2-((1-(3-fluorophenyl)cyclopentane-1- carbonyl)oxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-33 [00056]embedded image isopropyl 2-(2-(6,7-dimethoxy-4-oxoquinazolin- 3(4H)-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-34 [00057]embedded image isopropyl 2-(5-((4-chloro-3,5-dimethyl-1H-pyrazol-1- yl)methyl)furan-2-carboxamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-35 [00058]embedded image isopropyl 2-(2-((4-amino-5-(p-tolyl)-4H-1,2,4-triazol- 3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-36 [00059]embedded image isopropyl 6-methyl-2-(5-methylpyrazine-2- carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-37 [00060]embedded image ethyl 2-(2-((4-fluorophenyl)amino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-38 [00061]embedded image tert-butyl 6,6-dimethyl-2-(2- (methylsulfonyl)propanamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-39 [00062]embedded image ethyl 2-(2-(methyl(phenyl)amino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-40 [00063]embedded image tert-butyl 2-(2-(1H-pyrazol-1-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-41 [00064]embedded image ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3- carboxylate I-42 [00065]embedded image isopropyl 2-(1-methyl-1H-1,2,3-triazole-5- carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-43 [00066]embedded image tert-butyl 2-(2-(4-oxopyrazolo[1,5-d][1,2,4]triazin- 5(4H)-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-44 [00067]embedded image tert-butyl 2-(2-ethoxyacetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-45 [00068]embedded image ethyl 4,5-dimethyl-2-(2- (phenylthio)acetamido)thiophene-3-carboxylate I-46 [00069]embedded image isopropyl 2-(2-((4-methoxybenzyl)amino)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-47 [00070]embedded image Oxalic acid salt of isopropyl 2-(2-((3- hydroxypropyl)amino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-48 [00071]embedded image 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2- yl)amino)-2-oxoethyl 5-methylisoxazole-4- carboxylate I-49 [00072]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 6- oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate I-50 [00073]embedded image isopropyl 2-(2-((4-allyl-5-methyl-4H-1,2,4-triazol-3- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-51 [00074]embedded image ethyl 2-(2-((2-methoxyphenyl)amino)acetamido)-4,5- dimethylthiophene-3-carboxylate I-52 [00075]embedded image ethyl 2-(2-((5-methyl-1,3,4-thiadiazol-2- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-53 [00076]embedded image ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5- dimethylthiophene-3-carboxylate I-54 [00077]embedded image ethyl 2-(2-(3-cyanophenoxy)acetamido)thiophene-3- carboxylate I-55 [00078]embedded image ethyl 2-(2-((5-amino-1,3,4-thiadiazol-2- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-56 [00079]embedded image ethyl 4,5-dimethyl-2-(3- (phenylthio)propanamido)thiophene-3-carboxylate I-57 [00080]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5- methylpyrazine-2-carboxylate I-58 [00081]embedded image ethyl 2-(2-((1,3,4-thiadiazol-2- yl)thio)acetamido)thiophene-3-carboxylate I-59 [00082]embedded image ethyl 2-(2-(quinazolin-4-ylthio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-60 [00083]embedded image tert-butyl 2-(1-acetylpyrrolidine-3-carboxamido)-6,6- dimethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-61 [00084]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2,5-dimethylfuran-3-carboxylate I-62 [00085]embedded image Oxalic acid salt of isopropyl 2-(2-(4-methylpiperazin- 1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene- 3-carboxylate I-63 [00086]embedded image tert-butyl 2-(2-oxo-2-(1,3,5-trimethyl-1H-pyrazol-4- yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-64 [00087]embedded image isopropyl 2-(2-(4-(furan-2-carbonyl)piperazin-1- yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate I-65 [00088]embedded image Oxalic acid salt of isopropyl 2-(2- (ethylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-66 [00089]embedded image ethyl 4,5-dimethyl-2-(2-(thiophen-2- yl)acetamido)thiophene-3-carboxylate I-67 [00090]embedded image isopropyl 2-(2-(2-(4-oxo-3,4-dihydrophthalazin-1- yl)acetoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-68 [00091]embedded image isopropyl 2-(2-(1H-1,2,4-triazol-1-yl)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-69 [00092]embedded image ethyl 2-(2-(naphthalen-1-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-70 [00093]embedded image ethyl 2-(2-(p-tolylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-71 [00094]embedded image ethyl 2-(2-(adamantan-1-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-72 [00095]embedded image ethyl 2-(2-((5-amino-4H-1,2,4-triazol-3- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-73 [00096]embedded image 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2- yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate I-74 [00097]embedded image isopropyl 6-methyl-2-(2-(4-(4-nitrophenyl)piperazin- 1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene- 3-carboxylate I-75 [00098]embedded image 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2- yl)amino)-2-oxoethyl isonicotinate I-76 [00099]embedded image 1-(2-((3-(ethoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethyl)cyclopentane-1-carboxylic acid I-77 [00100]embedded image ethyl 2-(2-((1-methyl-1H-tetrazol-5- yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-78 [00101]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2- hydroxyquinoline-4-carboxylate I-79 [00102]embedded image ethyl 2-(2-([1,2,4]triazolo[4,3-a]pyridin-3- ylthio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-80 [00103]embedded image ethyl 2-(3-morpholinopropanamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-81 [00104]embedded image 4-((2-((3-(ethoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethoxy)carbonyl)pyridine 1-oxide I-82 [00105]embedded image ethyl 2-(3-(pyrrolidin-1-yl)propanamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt I-83 [00106]embedded image 2-((3-(ethoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5- methylfuran-2-carboxylate I-84 [00107]embedded image ethyl 2-(2-(1-methyl-3,4-dihydropyrrolo[1,2- a]pyrazin-2(1H)-yl)acetamido)thiophene-3- carboxylate I-85 [00108]embedded image ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5- dimethylthiophene-3-carboxylate I-86 [00109]embedded image ethyl 2-acetamido-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-87 [00110]embedded image ethyl 2-(2-cyanoacetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-88 [00111]embedded image ethyl 4,5-dimethyl-2-(2-(m- tolylamino)acetamido)thiophene-3-carboxylate I-89 [00112]embedded image ethyl 2-(4-methoxy-4-oxobutanamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-90 [00113]embedded image 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2- yl)amino)-2-oxoethyl pyrazine-2-carboxylate I-91 [00114]embedded image ethyl 2-(2-(cycloheptylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-92 [00115]embedded image ethyl 2-(2-((3,5-dimethylphenyl)amino)acetamido)- 4,5-dimethylthiophene-3-carboxylate I-93 [00116]embedded image ethyl 2-(2-((2,6-difluorobenzoyl)oxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-94 [00117]embedded image ethyl 4,5-dimethyl-2-(2-(o- tolyloxy)acetamido)thiophene-3-carboxylate I-95 [00118]embedded image 2-((3-(isopropoxycarbonyl)-4,5,6,7- tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2- (allylamino)thiazole-4-carboxylate I-96 [00119]embedded image 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2- yl)amino)-2-oxoethyl picolinate I-97 [00120]embedded image ethyl 2-(2-(benzoyloxy)acetamido)-4,5- dimethylthiophene-3-carboxylate I-98 [00121]embedded image ethyl 2-(2-((4- (methoxycarbonyl)phenyl)amino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-99 [00122]embedded image ethyl 2-(2-(benzylthio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-100 [00123]embedded image ethyl 2-(2-((1-methyl-4,5-dihydro-1H-imidazol-2- yl)thio)acetamido)thiophene-3-carboxylate I-101 [00124]embedded image ethyl 2-(2-(azepan-1-yl)acetamido)-4,5- dimethylthiophene-3-carboxylate I-102 [00125]embedded image ethyl 2-(2-((4-chlorobenzyl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-103 [00126]embedded image ethyl 2-(2-((1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5- dimethylthiophene-3-carboxylate I-104 [00127]embedded image Oxalic acid salt of ethyl 2-(2-(butylamino)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate I-105 [00128]embedded image ethyl 2-(2-((3- (trifluoromethyl)phenyl)amino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate I-106 [00129]embedded image ethyl 2-(2-(2,6-dimethylmorpholino)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

    [0083] Additional specific examples of apyrase inhibitors according to the present disclosure, including compounds of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), for use to enhance the activity of an agricultural or horticultural pesticide as described herein, are illustrated below in Table 2:

    TABLE-US-00002 TABLE 2 ID Structure Name II-1 [00130]embedded image ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-2 [00131]embedded image ethyl 2-(2-(4-fluorophenoxy)-N-methylacetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-3 [00132]embedded image 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylic acid II-4 [00133]embedded image methyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-5 [00134]embedded image isopropyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-6 [00135]embedded image tert-butyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-7 [00136]embedded image ethyl 2-(2-(4-fluorophenoxy)-2-methylpropanamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-9 [00137]embedded image ethyl 2-(2-((4-fluorophenyl)(methyl)amino)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-10 [00138]embedded image ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-11 [00139]embedded image ethyl 2-(2-((4-fluorophenyl)sulfonyl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-12 [00140]embedded image ethyl 2-(3-(4-fluorophenyl)propanamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-13 [00141]embedded image ethyl 2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-14 [00142]embedded image ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-15 [00143]embedded image ethyl 2-(2-(4-nitrophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-16 [00144]embedded image ethyl 2-(2-(p-tolyloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-17 [00145]embedded image ethyl 2-(2-(4-methoxyphenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-18 [00146]embedded image ethyl 2-(2-(3-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-19 [00147]embedded image ethyl 2-(2-(2-fluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-20 [00148]embedded image ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-21 [00149]embedded image ethyl 2-(2-(3-chloro-4-fluorophenoxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-22 [00150]embedded image ethyl 2-(2-(benzo[d][1,3]dioxol-5-yloxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-23 [00151]embedded image ethyl 2-(2-(4-(trifluoromethoxy)phenoxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-24 [00152]embedded image ethyl 2-(2-(3-(trifluoromethyl)phenoxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-25 [00153]embedded image ethyl 2-(2-(pyridin-4-yloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-26 [00154]embedded image ethyl 2-(2-(pyridin-3-yloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-27 [00155]embedded image ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-28 [00156]embedded image ethyl 2-(2-((tetrahydro-2H-pyran-4-yl)oxy)acetamido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate II-29 [00157]embedded image ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H- thieno[2,3-c]pyran-3-carboxylate II-30 [00158]embedded image ethyl 2-(2-(4- fluorophenoxy)acetamido)benzo[b]thiophene-3- carboxylate II-31 [00159]embedded image ethyl 2-(2-(4-fluorophenoxy)acetamido)-5-methyl-4-oxo- 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate II-32 [00160]embedded image ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H- thieno[2,3-c]thiopyran-3-carboxylate 6,6-dioxide II-33 [00161]embedded image ethyl 2-(2-phenoxyacetamido)-6,7-dihydro- 4H-thieno[3,2-c]pyran-3-carboxylate II-34 [00162]embedded image ethyl 2-(2-phenoxyacetamido)benzo[b]thiophene-3- carboxylate II-35 [00163]embedded image ethyl 5-methyl-4-oxo-2-(2-phenoxyacetamido)-4,5,6,7- tetrahydrothieno[3,2-c]pyridine-3-carboxylate II-36 [00164]embedded image ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H- thieno[3,2-c]thiopyran-3-carboxylate 5,5-dioxide II-37 [00165]embedded image ethyl 2-(2-((2-methylbenzoyl)oxy)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-38 [00166]embedded image ethyl 2-(2-(pyrazine-2-carboxamido)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate II-39 [00167]embedded image ethyl 2-(2-(N-methylpyrazine-2- carboxamido)acetamido)-4,5,6,7- II-40 [00168]embedded image tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H- thieno[2,3-c]thiopyran-3-carboxylate

    III. Target Crops and their Pathogens

    [0084] The present disclosure provides formulations and methods for their use in treating crops for pathogens. In one embodiment, a disclosed compound, such as a compound of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), is administered in combination with an agricultural or horticultural pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and/or nematocide. Crops that can be treated, include those plagued by various pathogens, including without limitation, bacteria, viruses, fungal pathogens, mites, nematodes, molluscs, weeds or other pests, as is known to those of ordinary skill in the agricultural arts. By way of example, such agricultural and horticultural crops that can be treated according to the present disclosure include plants, whether genetically modified or not, including their harvested products, such as: cereals; vegetables; root crops; potatoes; trees such as fruit trees, for example banana trees, tea, coffee trees, or cocoa trees; grasses; lawn grass; or cotton.

    [0085] Windsor and coworkers describe the compound:

    ##STR00169##

    ethyl 2-(2-(cyclohexylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate, referred to herein as Windsor compound XVI, as enhancing the ability of certain fungicides to inhibit the growth of different plant-pathogenic fungi (WO 2006/0276339). The present compounds surprisingly enhance the ability of a variety of pesticides against a broad variety of pathogens, including fungal pathogens. In addition, examples of the presently disclosed compound exhibit superior enhancer activity than Windsor compound XVI.

    [0086] The agricultural or horticultural enhancer disclosed herein may be applied to each part of plants, such as leaves, stems, patterns, flowers, buds, fruits, seeds, sprouts, roots, tubers, tuberous roots, shoots, or cuttings. The agricultural or horticultural enhancer according to the present disclosure may also be applied to improved varieties, cultivars, as well as mutants, hybrids and genetically modified embodiments of these plants.

    [0087] The agricultural or horticultural treatment described herein may be used to conduct seed treatment, foliage application, soil application, or water application, so as to control various diseases occurring in agricultural or horticultural crops, including flowers, lawns, and pastures.

    [0088] The present compounds are useful for potentiating the effects of antimicrobial agents. For example, the present compounds can be used in combination with an antimicrobial agent to combat bacterial and viral infection.

    [0089] The present compounds are useful for potentiating the effects of herbicides. For example, the present compounds can be used in combination with one or more herbicide to control weeds or other unwanted vegetation.

    [0090] The present compounds are useful for potentiating the effects of insecticides. For example, the present compounds can be used in combination with one or more insecticide to control insect infestation. The present compounds are useful for potentiating the effects of acaricides or miticides. For example, the present compounds can be used in combination with one or more acaricidal agent to control mites. The present compounds are useful for potentiating the effects of molluscicides. For example, the present compounds can be used in combination with one or more molluscicide to prevent interference of slugs or snails with a crop.

    [0091] The present compounds are useful for potentiating the effects of nematocides. For example, the present compounds can be used in combination with one or more nematocide to prevent interference of nematodes with a crop.

    [0092] The present compounds are particularly useful for potentiating the effects of fungicides against plant fungal pathogens. Examples of pathogens treated according to the present disclosure include, without limitation, Botrytis cinerea, Colletotrichum graminicola, Fusarium oxysporum, Sclerotiana sclerotiorum, Verticillium dahlia, Mycospharella gramincola and Sphacelotheca reliana.

    [0093] Botrytis cinerea is an airborne plant pathogen with a necrotrophic lifestyle attacking over 200 crop hosts worldwide. It mainly attacks dicotyledonous plant species, including important protein, oil, fiber and horticultural crops, grapes and strawberries and also Botrytis also causes secondary soft rot of fruits and vegetables during storage, transit and at the market. Many classes of fungicides have failed to control Botrytis cinerea due to its genetic plasticity.

    [0094] The genus Colletotrichum comprises 600 species attacking over 3,200 species of monocot and dicot plants. Colletotrichum graminicola primarily infects maize (Zea mays), causing annual losses of approximately 1 billion dollars in the United States alone (Connell et al., 2012).

    [0095] Fusarium wilt of banana, caused by the soil-borne fungus Fusarium oxysporum f.sp. cubense, is a major threat to banana production worldwide. No fungicides are currently available to effectively control the disease once plants are infected (Peng J et al., 2014).

    [0096] The white mold fungus Sclerotinia sclerotiorum is known to attack more than 400 host species and is considered one of the most prolific plant pathogens. The majority of the affected crop species are dicotyledonous, along with a number of agriculturally significant monocotyledonous plants. Some important crops affected by S. sclerotiorum include legumes (soybean), most vegetables, stone fruits and tobacco.

    [0097] The ascomycete Verticillium dahliae is a soil-borne fungal plant pathogen that causes vascular wilt diseases in a broad range of dicotyledonous host species. V. dahliae can cause severe yield and quality losses in cotton and other important crops such as vegetables, fibers, fruit, nut trees, forest trees and ornamental plants.

    [0098] The ascomycete fungus Mycospharella gramincola (anamorph: Septoria tritici) is one of the most important foliar diseases of wheat leaves, occurring wherever wheat is grown. Yield losses attributed to this disease range from 25%-50%, and are especially high in Europe, the Mediterranean region and East Africa. Infection by M. gramincola is initiated by air borne ascopores produced on residues of last season's crop. Primary infection usually occurs after seedlings emerge in spring or fall. The mature disease is characterized by necrotic lesions on the leaves and stems of infected plants.

    [0099] The basidiomycete fungus Sphacelotheca reliana infects corn (Zea mays) systemically, causing Head Smut. Yield loss attributed to the disease is variable, and is directly dependent on the incidence of the disease. The fungus overwinters as diploid teliospores in crop debris or soil. Floral structures are converted to sori containing masses of powdery teliospores that resemble mature galls of common smut.

    [0100] Examples of crops to be treated and plant diseases (pathogens) to be controlled using the presently disclosed compounds and compositions include, without limitation:

    [0101] Sugar beet: brown spot disease (Cercospora beticola), black root disease (Aphanomyces cochlioides), root rot disease (Thanatephorus cucumeris), leaf rot disease (Thanatephorus cucumeris), and the like.

    [0102] Peanut: brown spot disease (Mycosphaerella arachidis), leaf mold (Ascochyta sp.), rust disease (Puccinia arachidis), damping-off disease (Pythium debaryanum), rust spot disease (Alternaria alternata), stem rot disease (Sclerotium rolfsii), black rust disease (Mycosphaerella berkeleyi), and the like.

    [0103] Cucumber: powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis), gummy stem blight (Mycosphaerella melonis), wilt disease (Fusarium oxysporum), sclerotinia rot (Sclerotinia sclerotiorum), gray mold (Botrytis cinerea), anthracnose (Colletotrichum orbiculare), scab (Cladosporium cucumerinum), brown spot disease (Corynespora cassiicola), damping-off disease (Pythium debaryanum, Rhizoctonia solani Kuhn), Phomopsis root rot disease (Phomopsis sp.), Bacterial spot (Pseudomonas syringae pv. Lechrymans), and the like.

    [0104] Tomato: gray mold disease (Botrytis cinerea), leaf mold disease (Cladosporium fulvum), late blight disease (Phytophthora infestans), Verticillium wilt disease (Verticillium albo-atrum, Verticillium dahliae), powdery mildew disease (Oidium neolycopersici), early blight disease (Alternaria solani), leaf mold disease (Pseudocercospora fuligena), and the like.

    [0105] Eggplant: gray mold disease (Botrytis cinerea), black rot disease (Corynespora melongenae), powdery mildew disease (Erysiphe cichoracearum), leaf mold disease (Mycovellosiella nattrassii), sclerotinia rot disease (Sclerotinia sclerotiorum), Verticillium wilt disease (Verticillium dahlia), Mycosphaerella blight (Phomopsis vexans), and the like.

    [0106] Strawberry: gray mold disease (Botrytis cinerea), powdery mildew disease (Sphaerotheca humuli), anthracnose disease (Colletotrichum acutatum, Colletotrichum fragariae), phytophthora rot disease (Phytophthora cactorum), soft rot disease (Rhizopus stolonifer), fusarium wilt disease (Fusarium oxysporum), verticillium wilt disease (Verticillium dahlia), and the like.

    [0107] Onion: neck rot disease (Botrytis allii), gray mold disease (Botrytis cinerea), leaf blight disease (Botrytis squamosa), downy mildew disease (Peronospora destructor), Phytophthora porn disease (Phytophthora porn), and the like.

    [0108] Cabbage: clubroot disease (Plasmodiophora brassicae), soft rot disease (Erwinia carotovora), black rot disease (Xanthomonas campesrtis pv. campestris), bacterial black spot disease (Pseudomonas syringae pv. Maculicola, P. s. pv. alisalensis), downy mildew disease (Peronospora parasitica), sclerotinia rot disease (Sclerotinia sclerotiorum), black spot disease (Alternaria brassicicola), gray mold disease (Botrytis cinerea), and the like.

    [0109] Common bean: sclerotinia rot disease (Sclerotinia sclerotiorum), gray mold disease (Botrytis cinerea), anthracnose (Colletotrichum lindemuthianum), angular spot disease (Phaeoisariopsis griseola), and the like.

    [0110] Apple: powdery mildew disease (Podosphaera leucotricha), scab disease (Venturia inaequalis), Monilinia disease (Monilinia mali), black spot disease (Mycosphaerella pomi), valla canker disease (Valsa mali), alternaria blotch disease (Alternaria mali), rust disease (Gymnosporangium yamadae), ring rot disease (Botryosphaeria berengeriana), anthracnose disease (Glomerella cingulata, Colletotrichum acutatum), leaf rot disease (Diplocarpon mali), fly speck disease (Zygophiala jamaicensis), Sooty blotch (Gloeodes pomigena), violet root rot disease (Helicobasidium mompa), gray mold disease (Botrytis cinerea), and the like.

    [0111] Japanese apricot: scab disease (Cladosporium carpophilum), gray mold disease (Botrytis cinerea), brown rot disease (Monilinia mumecola), and the like.

    [0112] Persimmon: powdery mildew disease (Phyllactinia kakicola), anthracnose disease (Gloeosporium kaki), angular leaf spot (Cercospora kaki), and the like.

    [0113] Peach: brown rot disease (Monilinia fructicola), scab disease (Cladosporium carpophilum), phomopsis rot disease (Phomopsis sp.), bacterial shot hole disease (Xanthomonas campestris pv. pruni), and the like.

    [0114] Almond: brown rot disease (Monilinia taxa), spot blotch disease (Stigmina carpophila), scab disease (Cladosporium carpophilum), red leaf spot disease (Polystigma rubrum), alternaria blotch disease (Alternaria alternata), anthracnose (Colletotrichum gloeospoides), and the like.

    [0115] Yellow peach: brown rot disease (Monilinia fructicola), anthracnose disease (Colletotrichum acutatum), black spot disease (Alternaria sp.), Monilinia kusanoi disease (Monilinia kusanoi), and the like.

    [0116] Grape: gray mold disease (Botrytis cinerea), powdery mildew disease (Uncinula necator), ripe rot disease (Glomerella cingulata, Colletotrichum acutatum), downy mildew disease (Plasmopara viticola), anthracnose disease (Elsinoe ampelina), brown spot disease (Pseudocercospora vitis), black rot disease (Guignardia bidwellii), white rot disease (Coniella castaneicola), rust disease (Phakopsora ampelopsidis), and the like.

    [0117] Pear: scab disease (Venturia nashicola), rust disease (Gymnosporangium asiaticum), black spot disease (Alternaria kikuchiana), ring rot disease (Botryosphaeria berengeriana), powdery mildew disease (Phyllactinia mali), Cytospora canker disease (Phomopsis fukushii), brown spot blotch disease (Stemphylium vesicarium), anthracnose disease (Glomerella cingulata), and the like.

    [0118] Tea: ring spot disease (Pestalotiopsis longiseta, P. theae), anthracnose disease (Colletotrichum theae-sinensis), Net blister blight (Exobasidium reticulatum), and the like.

    [0119] Citrus fruits: scab disease (Elsinoe fawcettii), blue mold disease (Penicillium italicum), common green mold disease (Penicillium digitatum), gray mold disease (Botrytis cinerea), melanose disease (Diaporthe citri), canker disease (Xanthomonas campestris pv. Citri), powdery mildew disease (Oidium sp.), and the like.

    [0120] Wheat: powdery mildew (Blumeria graminis f sp. tritici), red mold disease (Gibberella zeae), brown rust disease (Puccinia recondita), brown snow mold disease (Pythium iwayamai), pink snow mold disease (Monographella nivalis), eye spot disease (Pseudocercosporella herpotrichoides), leaf scorch disease (Septoria tritici), glume blotch disease (Leptosphaeria nodorum), typhula snow blight disease (Typhula incarnata), sclerotinia snow blight disease (Myriosclerotinia borealis), damping-off disease (Gaeumannomyces graminis), ergot disease (Claviceps purpurea), stinking smut disease (Tilletia caries), loose smut disease (Ustilago nuda), and the like.

    [0121] Barley: leaf spot disease (Pyrenophora graminea), net blotch disease (Pyrenophora teres), leaf blotch disease (Rhynchosporium secalis), loose smut disease (Ustilago tritici, U. nuda), and the like.

    [0122] Rice: blast disease (Pyricularia oryzae), sheath blight disease (Rhizoctonia solani), bakanae disease (Gibberella fujikuroi), brown spot disease (Cochliobolus miyabeanus), damping-off disease (Pythium graminicola), bacterial leaf blight (Xanthomonas oryzae), bacterial seedling blight disease (Burkholderia plantarii), brown stripe disease (Acidovorax avenae), bacterial grain rot disease (Burkholderia glumae), Cercospora leaf spot disease (Cercospora oryzae), false smut disease (Ustilaginoidea virens), rice brown spot disease (Alternaria alternata, Curvularia intermedia), kernel discoloration of rice (Alternaria padwickii), pink coloring of rice grains (Epicoccum purpurascens), and the like.

    [0123] Tobacco: sclerotinia rot disease (Sclerotinia sclerotiorum), powdery mildew disease (Erysiphe cichoracearum), phytophthora rot disease (Phytophthora nicotianae), and the like.

    [0124] Tulip: gray mold disease (Botrytis cinerea), and the like.

    [0125] Sunflower: downy mildew disease (Plasmopara halstedii), sclerotinia rot disease (Sclerotinia sclerotiorum), and the like.

    [0126] Bent grass: Sclerotinia snow blight (Sclerotinia borealis), Large patch (Rhizoctonia solani), Brown patch (Rhizoctonia solani), Dollar spot (Sclerotinia homoeocarpa), blast disease (Pyricularia sp.), Pythium red blight disease (Pythium aphanidermatum), anthracnose disease (Colletotrichum graminicola), and the like.

    [0127] Orchard grass: powdery mildew disease (Erysiphe graminis), and the like.

    [0128] Soybean: purple stain disease (Cercospora kikuchii), downy mildew disease (Peronospora manshurica), phytophthora rot disease (Phytophthora sojae), rust disease (Phakopsora pachyrhizi), sclerotinia rot disease (Sclerotinia sclerotiorum), anthracnose disease (Colletotrichum truncatum), gray mold disease (Botrytis cinerea), Sphaceloma scab (Elsinoe glycines), melanoses (Diaporthe phaseolorum var. sojae), and the like.

    [0129] Potato: hytophthora rot disease (Phytophthora infestans), early blight disease (Alternaria solani), scurf disease (Thanatephorus cucumeris), verticillium wilt disease (Verticillium albo-atrum, V. dahlia, V. nigrescens, and the like.

    [0130] Banana: Panama disease (Fusarium oxysporum), Sigatoka disease (Mycosphaerella fijiensis, M. musicola), and the like.

    [0131] Rapeseed: sclerotinia rot disease (Sclerotinia sclerotiorum), root rot disease (Phoma lingam), black leaf spot disease (Alternaria brassicae), and the like.

    [0132] Coffee: rust disease (Hemileia vastatrix), anthracnose (Colletotrichum coffeanum), leaf spot disease (Cercospora coffeicola), and the like.

    [0133] Sugarcane: brown rust disease (Puccinia melanocephala), and the like.

    [0134] Corn: zonate spot disease (Gloeocercospora sorghi), rust disease (Puccinia sorghi), southern rust disease (Puccinia polysora), smut disease (Ustilago maydis), brown spot disease (Cochliobolus heterostrophus), northern leaf blight (Setosphaeria turcica), and the like.

    [0135] Cotton: seedling blight disease (Pythium sp.), rust disease (Phakopsora gossypii), sour rot disease (Mycosphaerella areola), anthracnose (Glomerella gossypii), and the like.

    IV. Pesticides

    [0136] The presently disclosed compounds, including compounds according to (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), are useful for enhancing the effect of a variety of agrochemicals, including fungicides, antiviral agents, bactericides, herbicides, insecticidal/acaricidal agents, molluscicides, nematicides, soil pesticides, plant control agents, synergistic agents, fertilizers and soil conditioners.

    [0137] In one embodiment, the presently disclosed compounds are useful for enhancing the fungicidal effect of a variety of fungicides. Fungicides for use with the presently disclosed compounds, such as a compound of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), are well known to those of skill in the art and include, without limitation those set forth by class in Table 3:

    TABLE-US-00003 TABLE 3 Family & Group # Common Names Trade Names (Combination Products) Benzimidazole benomyl Benlate, Tersan 1991 (Group 1) thiabendazole Arbotect 20-S, Decco Salt No. 19, LSP Flowable Fungicide, Mertect 340-F thiophanate-methyl Cavalier, Cleary's 3336, OHP 6672, Regal SysTec, Tee-Off, T-Methyl 4.5F AG, TM 85, Topsin M Dicarboximide iprodione Epic 30, Ipro, Meteor, Nevado, OHP Chipco (Group 2) 26019, Rovral, (Interface) vinclozolin Curalan, Ronilan Phenylpyrroles fludioxonil Cannonball, Emblem, Maxim, Medallion, (Group 12) Mozart, Scholar, Spirato, (Academy, Miravis Prime, Palladium, Switch) Anilinopyrimidines cyprodinil Vangard (Palladium, Switch, Inspire Super) (Group 9) pyrimethanil Penbotec, Scala, (Luna Tranquility) Hydroxyanilide fenhexamid Decree, Elevate, Judge (Group 17) fenpyrazamine Protexio Carboxamide boscalid Emerald, Endura, (Encartis, Honor, Pageant, (Group 7) Pristine) carboxin Vitavax fluopyram Luna Privilege, Velum Prime (Broadform, Luna Experience, Luna Sensation, Luna Tranquility, Propulse) flutolanil Contrast, Moncut, ProStar fluxapyroxad (Lexicon, Merivon, Orkestra) inpyrfluxam Excalia isofetamid Kenja oxycarboxin Carboject, Plantvax penthiopyrad Fontelis, Velista, Vertisan pydiflumetofen Miravis, Posterity, Miravis Ace A (Miravis Neo, Miravis Prime, Miravis Duo, Miravis Top) solatenol Aprovia (Contend A, Elatus, Mural) (benzovindiflupyr) Phenylamide (Group 4) mefenoxam Apron, Ridomil Gold, Subdue MAXX, (Quadris Ridomil Gold, Uniform) metalaxyl Acquire, Allegiance, MetaStar, Ridomil, Sebring, Subdue oxadixyl Anchor Phosphonate (Group P7) aluminum tris Aliette, Flanker, Legion, Signature, Areca Phosphorous Acid Agri-Fos, Alude, Appear, Fiata, Fosphite, Phospho Jet, Phostrol, Rampart, Reload Cinnamic acid (Group 40) dimethomorph Forum, Stature, (Orvego, Zampro) mandipropamid Micora, Revus, (Revus Top) OSBPI (Group 49) oxathiapiprolin Segovis Triazoles carboxamide ethaboxam V-10208 (Group 22) Group 27 cymoxanil Curzate, (Tanos) Carbamate (Group 28) propamocarb Banol, Previcur, Proplant, Tattoo Benzamide (Group 43) fluopicolide Adorn, Presidio Demethylation-inhibiting (Group 3) Piperazines triforine Funginex, Triforine Pyrimidines fenarimol Focus, Rubigan, Vintage Imidazole imazalil Fungaflor, (Raxil MD Extra) triflumizole Procure, Terraguard, Trionic Triazoles cyproconizole Sentinel difenoconazole Dividend, Inspire, (Academy, Briskway, Contend A, Inspire Super, Quadris Top, Revus Top) Miravis Duo fenbuconazole Enable, Indar flutriafol Topguard, (Topguard EQ) mefentrifluconazole Maxtima (Navicon) metconazole Quash, Tourney ipconazole Rancona myclobutanil Eagle, Hoist, Immunox, Laredo, Nova, Rally, Sonoma, Systhane propiconazole Alamo, Banner, Break, Bumper, Infuse, Kestrel Mex, Miravis Ace B, PropiMax, ProPensity, Strider, Tilt, Topaz, (Aframe Plus, Concert, Contend B, Headway, Quilt Xcel, Stratego) prothioconazole Proline (Propulse) tebuconazole Bayer Advanced, Elite, Folicur, Lynx, Mirage, Orius, Raxil, Sativa, Tebucon, Tebuject, Tebusha, Tebustar, Toledo, (Absolute, Luna Experience, Unicorn), etc. tetraconazole Mettle triadimefon Bayleton, Strike, (Armada, Tartan, Trigo) triadimenol Baytan triticonazole Charter, Trinity, (Pillar) Morpholine (Group 5) piperalin Pipron spiroxamine Accrue Group U6 cyflufenamid Torino Group 50 metrafenone Vivando pyriofenone Prolivo QoI Strobilurins azoxystrobin Abound, Aframe, Dynasty, Heritage, Prott, (Group 11) Quadris, Quilt, (Aframe Plus, Briskway, Contend B, Dexter Max, Elatus, Headway, Mural, Quadris Top, Quilt Xcel, Renown, Topguard EQ, Uniform) femoxadone (Tanos) fenamidone Fenstop, Reason fluoxastrobin Aftershock, Disarm, Evito, Fame kresoxim-methyl Cygnus, Sovran mandestrobin Intuity, Pinpoint picoxystrobin Aproach pyraclostrobin Cabrio, Empress, Headline, Insignia, Stamina, (Honor, Lexicon, Merivon, Navicon, Orkestra, Pageant, Pillar, Pristine) trifloxystrobin Compass, Flint, Gem, (Absolute, Armada, Broadform, Interface, Luna Sensation, Stratego, Tartan, Trigo) Quinoline (Group 13) quinoxyfen Quintec Inorganic Compounds Coppers (Group M1) bordeaux None copper ammonium Copper Count-N complex copper hydroxide Champ, Champion, Kalmor, Kentan, Kocide, Nu-Cop copper oxide Nordox copper oxychloride COCS, Oxycop copper sulfate Cuprofix Disperss, many others Sulfur (Group M2) sulfur Cosavet, Kumulus, Microthiol Disperss, Thiosperse Lime sulfur Ca polysulfides Lime Sulfur, Sulforix Ethylenebisdithiocarbamates mancozeb Dithane, Fore, Penncozeb, Protect, Manex, (EBDC) (Group M3) Manzate, Roper, Wingman, (Dexter Max, Gavel) maneb Maneb metiram Polyram EBDC-like (Group M3) ferbam Carbamate, Ferbam thiram Difiant, Spotrete, Thiram ziram Ziram Aromatic Hydrocarbon dicloran (DCNA) Allisan, Botran (Group 14) etridizole Terrazole, Truban pentachloronitrobenzene Autilus, Defend, Engage, PCNB, Terraclor, (Premion) Chloronitrile (Group M5) chlorothalonil Bravo, Daconil, Docket, Echo, Ensign, Exotherm Termil, Funginil, Legend, Manicure, Pegasus, Terranil, (Concert, Spectro) Phthalimides (Group M4) captan Captan Guanidines (Group U12) dodine Syllit QiI fungicides (Group 21) cyazofamid Ranman, Segway Polyoxin (Group 19) polyoxin Affirm, Endorse, Oso, Ph-D, Tavano, Veranda Group 29 fluazinam Omega, Secure Thiazolidine (U13) flutianil Gatten

    [0138] Fungicides are cataloged more broadly by the Fungicide Resistance Action Committee (FRAC) in the FRAC Code List 2022 and reproduced in Appendix 1 and which is incorporated herein by reference in its entirety.

    [0139] In one embodiment, a presently disclosed enhancer compound, such as a compound of Formulas Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), is used in combination with one or more compound from the Families or Groups set forth in Table 3, Appendix 1, or both. In certain embodiments, a presently disclosed enhancer is used in combination with one or more fungicides recited in column 1 of Table 3.

    [0140] In particular embodiments, a disclosed enhancer is used in combination with one or more of a fungicide selected from the benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles, and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam and thiazolidines.

    [0141] Particular fungicides that are potentiated by use in combination with an enhancer according to the methods herein by administration of an apyrase inhibitor are coppers, such as copper octanoate, copper hydroxide and the like, myclobutanil, propiconazole, tebuconazole, epoxiconazole, difenoconazole, triticonazole, and prothioconazole.

    [0142] In one embodiment, the combined treatment with a selected fungicide and an enhancer according to the present disclosure, such as a compound of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), provides synergistic fungicidal activity against plant pathogenic fungi.

    [0143] In one embodiment, the disclosure provides compositions and methods of treating plants or plant seeds infected with or at risk of being infected with a fungal pathogen. In one embodiment compositions of the present disclosure comprise a formulation of a fungicide, an enhancer and a phytologically acceptable carrier. In another embodiment, the fungicide and enhancer are administered in separate compositions. In further embodiments, an agricultural or horticultural fungicide is used in combination with other compounds in addition to the presently disclosed apyrase inhibitors. As with the apyrase inhibitors, such other compounds can be administered in the same or separate compositions as the fungicide. Examples of the other components include known carriers to be used to conduct formulation. Additional examples thereof include conventionally-known herbicides, insecticidal/acaricidal agents, nematodes, soil pesticides, plant control agents, synergistic agents, fertilizers, soil conditioners, and animal feeds. In one embodiment, the inclusion of such other components yields synergistic effects on crop growth.

    [0144] In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and/or (Ib7), are used to potentiate the effect of a herbicide. Exemplary herbicides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 2. By way of example, suitable herbicides for use in combination with the present compounds include inhibitors of acetyl CoA synthase, inhibitors of acetolactate synthesis, inhibitors of microtubule assembly, inhibitors of microtubule organization, auxin mimics, photosynthesis inhibitors, deoxy-D-xylulose phosphate synthase inhibitors, enolpyruvyl shikimate phosphate synthase inhibitors, phytoene desaturase inhibitors, glutamine synthetase inhibitors, dihydropteroate synthesis inhibitors, protoporphyrinogen oxidase inhibitors, cellulose synthesis inhibitors, uncouplers, hydroxyphenyl pyruvate dioxygenase inhibitors, fatty acid thioesterase inhibitors, serine-threonine protein phosphatase inhibitors, solanesyl diphosphate synthase inhibitors, inhibitors of very long-chain fatty acid synthesis, homogentisate solanesyltransferase inhibitors, lycopene cyclase inhibitors,

    [0145] In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), are used to potentiate the effect of an insecticide. Exemplary insecticides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 3.

    V. Formulations

    [0146] The present disclosure provides specific apyrase inhibitors, such as compounds of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), to enhance the potency of pesticides to effectively restrict the growth of plant pathogenic species. In certain non-limiting embodiments, the apyrase inhibitors can be provided at: from about 0.01 to about 80% weight to weight in a final composition, or from about 25% to about 55%, such as from about 30% to about 50%, from about 35% to about 45%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 20, 30, 40, 50, 55, 60 or 80% weight to weight in a final composition. In one embodiment the apyrase inhibitors are provided in liquid form at from about 0.01 to about 50%, such as from about 15% to about 50%, from about 20% to about 45%, from about 25% to about 40%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 15, 20, 30, 40 or 50% volume to volume in a final diluted composition. The skilled artisan will recognize that the formulation of the pesticide, the apyrase inhibitor or a combination thereof can be provided in a concentrate that can be diluted prior to use, or can be provided in a diluted form ready for treatment.

    [0147] The enhancer, pesticide and combinations thereof are not particularly limited by the dosage form. Examples of the dosage form include wettable powders, emulsions, emulsifiable concentrates, oil-dispersible liquids, powders, granules, water-soluble agents, suspensions, granular wettable powders, and tablets. The method for preparing formulation is not particularly limited, and conventionally-known methods may be adopted depending on the dosage form.

    [0148] Several formulation examples are described below. The preparation formulations shown below are merely examples, and may be modified within a range not contrary to the essence of the present disclosure. For example, additional active and inert components may be added to the formulations below.

    [0149] Part means part by mass unless otherwise specified.

    Formulation Example 1: Wettable Powders

    [0150] 40 parts of an enhancer disclosed herein, 53 parts of diatomaceous earth, 4 parts of ethoxylated higher alcohol sulfate ester combined with a suitable solid carrier such as magnesium sulfate, and 3 parts of alkyl naphthalene sulfonate are mixed uniformly, and then finely pulverized to obtain wettable powders containing 40 parts by mass of the enhancer.

    Formulation Example 2: Emulsifiable Concentrates

    [0151] 3 parts of an enhancer disclosed herein, 60 parts of mixed petroleum distillates, 27 parts of dimethyl lactamide, and 10 parts of tristyrylphenol ethoxylates are mixed and dissolved to obtain an emulsifiable concentrate containing 3% by mass of the enhancer.

    Formulation Example 3: Granules

    [0152] 5 parts of an enhancer disclosed herein, 10 parts of talc, 38 parts of clay, 10 parts of bentonite, 30 parts of sodium lignosulfonate and 7 parts of sodium alkyl sulfate are mixed uniformly, and then finely pulverized, followed by conducting fluidized bed granulation to make the median particle diameter thereof be 0.2 to 2.0 mm, and thus granules containing 5% by mass of an enhancer on a dry weight basis disclosed herein are obtained.

    Formulation Example 4: Granules

    [0153] 5 parts of an enhancer disclosed herein, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctyl sulfosuccinate, and 1 part of potassium phosphate are mixed and then pulverized, followed by adding water thereto, and then kneading the mixture. Then, extrusion granulation is conducted, and the resultant is dried to obtain granules containing 5% by mass of the enhancer on a dry weight basis.

    Formulation Example 5: Suspensions

    [0154] 10 parts of an enhancer disclosed herein, 4 parts of polyoxyethylene alkyl ether, 2 parts of 3 kDa sodium polycarboxylate as dispersant, 10 parts of glycerin, 0.2 parts of xanthan gum, 0.1 parts of biocides as stabilizer, 0.1 parts of organosilicone antifoam emulsion and 73.6 parts of water are mixed, and then wet pulverized until the particle size is 3 microns or less to obtain a suspension containing 10% by mass of the enhancer.

    Formulation Example 6: Oil Dispersible Concentrates

    [0155] 40 parts of an enhancer disclosed herein, 5 parts of Atlox 4914, 5 parts of organo-modified bentonite and 50 parts of methylated rapeseed oil as carrier are mixed uniformly and then wet pulverized until the median particle size is 3 microns or less to obtain an oil dispersible concentrate containing 40% by mass of the enhancer.

    [0156] The skilled artisan will recognize that the various compositions are used commercially at varying concentrations and formulations. For example, it is common for fungicides to be formulated as liquids commercially at 10-40% concentrations. In one embodiment, the presently disclosed enhancers allow the use of a lower amount of a given fungicide due to the enhanced efficacy of fungicide in combination with an enhancer disclosed herein.

    vi. Methods for Assessing Enhancer Activity

    [0157] Apyrase inhibitors useful as enhancers of pesticidal activity are assessed using an in vitro assay. The method of Windsor, Bio Techniques 33:1024-1030 (November 2002) was used as follows

    Screen for Apyrase Inhibitors

    [0158] 96 well plates were used for the assay: (Greiner bio-one: REF-655901-96 well, PS, F-bottom, Clear, Non-binding)

    Buffers:

    [0159] Reaction Buffer: 60 mM Hepes; 3 mM MgCl.sub.2, 3 mM CaCl.sub.2 and 3 mM ATP (pH 6.5) [0160] Development Buffer A: 2% aqueous ammonium molybdate [0161] Development Buffer B: 11% ascorbic acid in 37.5% TCA in water [0162] Stop buffer C: 2% trisodium citrate in 2% acetic acid solution in water [0163] Add 100 l of reaction buffer to each well. [0164] Add 10 l of DMSO (control) or inhibitor/compound or compounds such as N1915 or orthovanadate to each well. (use inhibitor conc at 1 mM; orthovanadate at 2 mM and N1915 at 1 mM) [0165] Add 10 l of apyrase (concentration based on optimizationDilute 1 U/l enzyme to different concentrations such as 0.1 U, 0.05 U, 0.0025, 0.001 U, 0.0005 Uto find a good range) [0166] Incubate plate at room temperature for Ihr [0167] Mix development buffer A and B in the ratio of 1:1.5 (just before use). [0168] Add 50 ul of A:B mix in each well (incubate for 2 mins) [0169] Add 50 ul of C in each well [0170] Measure/Read Absorbance of plate @630 nm

    [0171] Inhibitory data for the apyrase assay described above are provided for selected compounds in Table 4. In Table 4, D indicates inhibition of <10%, C indicates inhibition of from 10% to 20%, B indicates inhibition of from 20% to 30%, and A indicates inhibition above 30%:

    TABLE-US-00004 TABLE 4 ID % Inhibition of Apyrase I-1 A I-2 A I-3 A I-4 A I-5 A I-6 A I-7 A I-8 A I-9 A I-10 A I-11 A I-12 A I-13 A I-14 A I-15 A I-16 A I-17 A I-18 A I-19 A I-20 A I-21 A I-22 A I-23 A I-24 A I-25 A I-26 A I-27 A I-28 A I-29 A I-30 A I-31 A I-32 A I-33 A I-34 A I-35 A I-36 A I-37 A I-38 B I-39 B I-40 B I-41 B I-42 B I-43 B I-44 B I-45 B I-46 B I-47 B I-48 B I-49 B I-50 B I-51 B I-52 B I-53 B I-54 B I-55 B I-56 B I-57 B I-58 B I-59 B I-60 B I-61 B I-62 B I-63 C I-64 C I-65 C I-66 C I-67 C I-68 C I-69 C I-70 C I-71 C I-72 C I-73 C I-74 C I-75 C I-76 C I-77 C I-78 C I-79 C I-80 C I-81 D I-82 D I-83 D I-84 D I-85 D I-86 D I-87 D I-88 D I-89 D I-90 D I-91 D I-92 D I-93 D I-94 D I-95 D I-96 D I-97 D I-98 D I-99 D I-100 D I-101 D I-102 D I-103 D I-104 D I-105 D I-106 D II-1 A II-2 A II-3 A II-4 A II-5 A II-6 A II-7 A II-9 II-10 A II-11 A II-12 A II-13 II-14 A II-15 A II-16 A II-17 D II-18 A II-19 A II-20 D II-21 B II-22 D II-23 A II-24 A II-25 A II-26 A II-27 D II-28 D II-29 A II-30 A II-31 II-32 A II-33 II-34 II-35 II-36 II-37 A II-38 II-39 II-40 A
    With reference to Table 4, percent inhibition of apyrase is reported as the rounded average of at least two assay results.

    Method 2: In Vitro Assessment of Combination Activity

    [0172] Selected compounds are assessed in combination with fungicides against a range of commercially important plant pathogenic fungi.

    [0173] The test is conducted as follows. A fungicide is applied to a fungal plant pathogen at a rate slightly below that at which gives any control, in combination with a suitable dose of the test compound. The test compound is recorded as active if control of the pathogen is observed.

    [0174] In more detail, the test is conducted as follows. For each combination of fungicide, pathogen and test compound, the following wells are used. Well 1 contains a fungal pathogen growing on agar, and a fungicide at a rate just below that at which it gave any control of the pathogen. Well 2 is the same as Well 1, except that the test compound is also added at Rate 1. Well 3 is the same as Well 2, except that the test compound is added at Rate 2, where Rate 2 is higher than Rate 1. Finally, as a benchmark, Well 4 is the same as Well 1, except that it contains the fungicide at a higher rate, at which it gives partial control of the pathogen. Each of the Wells 1 to 4 are run in duplicate, giving a total of 8 wells for each combination of fungicide, pathogen and test compound. For each well, after a suitable period of incubation, a visual assessment of the % control of the pathogen by the fungicide is made. Test compounds are scored as inactive, active or highly active.

    [0175] The following fungicides are used in this assay: azoxystrobin, fluxapyroxad, and desthio prothioconazole. The following fungal pathogens are used in this assay: First, a strain of Zymoseptoria tritici with a reduced susceptibility to strobilurin fungicides; second a strain of Zymoseptoria tritici with a reduced susceptibility to SDHI fungicides (i.e., those that inhibit succinate dehydrogenase); and third, Microdochium nivale. In this assay, exemplary compounds show significant activity in the combination assay and superior to that of the fungicide alone.

    Method 3: Greenhouse Crop Tests

    [0176] In this method, exemplary compounds were evaluated for their ability to control Brown Rust (Puccinia recondita) on wheat, in a controlled greenhouse environment in combination with one of four fungicides, Amistar, Imtrex, Proline or Balaya. In these studies, JB Diego wheat plants were used. Seeds were sown in 9 cm diameter pots to a depth of 1 to 2 cm using Petersfield potting compost (75% medium grade peat, 12% screened sterilized loam, 3% medium grade vermiculite, 10% grit (5 mm screened, lime free), 1.5 kg PG mix per m3, lime to pH5.5-6.0 and wetting agent (Vitax Ultrawet 200 ml per m3) and germinated/grown at 23 C under a 16 h day/8 h night light regime. Plants were treated two to three weeks after sowing when they were at the BBCH 11 growth stage (first pair of true leaves (unifoliate) unfolded. A track sprayer was used to treat the plants with the mixture of commercial fungicide and test compound using a water volume of 200 L/ha; enhancer test compound was included at 20 ppm. Plants were inoculated with the Puccinia triticina (Brown rust on wheat plants) 24 hours after treatment. Four replicates were used for each combination of fungicide and test compound. Each plant was evaluated at fourteen days (once the disease symptoms were fully expressed) for % control of the disease. Appropriate controls were used for all experiments, including an inoculation check wherein plants were inoculated with their specific pathogen to assess disease levels. Also, each commercial fungicide was tested on its own as a part of each treatment, this being benchmark against which the experimental compounds were evaluated. Exemplary compounds demonstrated enhanced disease control in combination with fungicides as compared to disease control observed with fungicide alone. That is, the present compounds, although not fungicidal by themselves, enhance the activity of fungicides, thus the enhancer compounds work synergistically in combination with fungicides to control disease.

    [0177] In these studies the fungicide was applied at the following rates:

    TABLE-US-00005 Amistar Imtrex Proline Balaya Brown Rust 0.033 L/ha 0.38 L/ha 0.72 L/ha 0.215 L/ha
    In this method, working examples enhanced the activity of Amistar against Brown Rust on wheat by significant amounts relative to the activity of Amistar alone. Compounds I-1, I-5, I-6 and I-7 all provided greater than 50% additional disease control benefit in combination with Amistar over Amistar alone. In contrast, Windsor compound XVI only provided 17.1% enhancement of Brown Rust control relative to Amistar alone. The superior activity of the presently disclosed compounds in potentiating the effect of fungicides in the greenhouse study is significant and unexpected in view of the in vitro apyrase inhibitory data for these compounds. For example, Windsor compound XVI exhibited superior apyrase inhibitory activity in vitro than present compound I-5, but was far less active than this compound in enhancing the activity of fungicides, including Amistar, against Brown Rust on wheat.

    [0178] Working examples also enhanced the activity of Imtrex against Brown Rust on wheat by significant amounts relative to Imtrex treatment alone. For example, compound I-1 provided greater than 50% additional disease control benefit in combination with Imtrex over Imtrex alone. Compounds I-5 and I-6 provided greater than 30% additional Brown Rust control relative to Imtrex alone, and compound I-7 provided greater than 20% additional Brown Rust control in combination with Imtrex over Imtrex alone. In contrast, Windsor compound XVI only provided 4.3% enhancement of Brown Rust control relative to Imtrex alone.

    [0179] Working example I-1 enhanced the activity of Balaya against Brown Rust on wheat by over 50% over Balaya alone. Working examples I-5, and I-7 provided greater than 30% additional Brown Rust control benefit in combination with Balaya over Balaya alone. In contrast, Windsor compound XVI provided 27.6% enhancement additional Brown Rust control in combination with Balaya over Balaya alone.

    Method 4: Enhancement of Herbicide Activity

    [0180] This method demonstrates the enhancement of herbicidal activity provided by the present compounds. Specifically, Amaranthus retroflexus (pigweed) was treated pre-emergence with metribuzin alone or in combination with an enhancer compound disclosed herein. Fifteen seeds of Amaranthus retroflexus were sown in soil in each pot and then sprayed with a mixture of metribuzin at the appropriate rate shown in Table 5 and the compound of this invention at 100 g/ha using a track sprayer at a water volume of 200 L/hectare. Small amounts of acetone were used to aid solubility. The pots were watered immediately after sowing and treatment and then allowed to stand in a glasshouse. Assessment of kill was made seven and fourteen days after treatment. The test included four replicates for each treatment and the control. Results are shown in Table 5. Exemplary compounds demonstrated significant enhancement of metribuzin herbicidal activity at seven and fourteen days.

    TABLE-US-00006 TABLE 5 Pre-Emergence Amaranthus Kill Percentage Assessed 7 DAT Assessed 14 DAT Enhancer Metribuzin rate (g/ha) Metribuzin rate (g/ha) Compound 0 50 100 200 0 50 100 200 None 0.0 0.0 15.2 60.9 4.8 7.7 38.3 74.0 (metribuzin only) I-6 9.3 85.2 100.0 17.4 87.5 100.0 I-4 0.0 50.0 92.1 18.5 66.7 98.4 I-5 24.5 80.0 100.0 45.5 80.4 100.0 I-2 0.0 61.2 95.9 13.3 68.6 100.0

    VII. Methods for Making Enhancer Compounds

    [0181] Exemplary enhancer compounds were purchased from commercial suppliers, such as Enamine, located at Industriepark Hoechst, G837. 65926 Frankfurt am Main Germany.

    [0182] Compounds disclosed herein, including compounds of Formulas (I), (Ia), (Ib), (Ia1), (Ib1), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), can be prepared as will be understood by those of skill upon consideration of the present disclosure.

    Analytical Methods

    LCMS Methodology

    [0183] Electrospray mass spectroscopy (MS) was carried out using the following method;

    LCMS (Agilent-Acid):

    [0184] LC model: Agilent 1260 (Pump type: Binary Pump, Detector type: DAD) MS model: Agilent G6125B Quadrupole. Column: Nanochrom x ChromCore C18 3 m 4.6*50 mm. Column temperature: 40 C. Acquisition of wavelength: 214 nm, 254 nm. Mobile phase: A: 0.04% TFA aqueous solution, B: ACN (0.02% TFA). Run time: 3 min. MS: Ion source: ES+. MS range: 100-1400 m/z. Fragmentor: 70. Drying gas flow: 12 L/min. Nebulizer pressure: 35 psi. Drying gas temperature: 350 C. Vcap: 3.5 kV.

    [0185] UPLC (Waters-Acid): Instrument type: Waters Acquity UPLC. Pump type: Binary Pump. Detector type: PDA. LC conditions: Column: YMC-Triart C18 ExRS, 3 m 2.1*100 mm. Acquisition wavelength: 214 nm, 254 nm. Mobile Phase: A: 0.02% TFA aqueous solution, B: ACN (0.02% TFA).

    [0186] Instrument type: Waters Acquity UPLC. Pump type: Binary Pump. Detector type: PDA. LC conditions: Column: YMC-Triart C18 ExRS, 3 m 2.1*100 mm. Acquisition wavelength: 214 nm, 254 nm. Mobile Phase: A: 10 mmol NH4HCO3 aqueous solution, B:ACN.

    NMR

    [0187] Nuclear magnetic resonance spectra were recorded on a Bruker Avance III 400 MHz instrument at 400 MHz for 1H nuclei as specified. Samples were recorded in deuterated solvent as specified, and data acquired at 25 C. Chemical shifts are reported in ppm on the 6 scale and referenced to the appropriate solvent peak. In reporting spectral data, the following abbreviations have been used: s, singlet; br s, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet.

    Synthesis of Enhancer Compounds

    [0188] Scheme 1 illustrates a suitable preparation for compounds of Formula (I) disclosed herein.

    ##STR00170##

    With reference to Scheme 1, generally, the substituted thiophene starting material (commercially available), is reacted with an activated carboxyl group in the presence of a hindered amine base, such as triethylamine, pyridine and/or 4-dimethylaminopyridine. Additional methods for synthesizing amide compounds of Formula (I) are known to those of skill in the art and for example in Bioorganic & Medicinal Chemistry Letters 2023, 79, 129069 (reaction with acid chloride), and European Journal of Medicinal Chemistry 2016, 122, 619-634 (reaction with acids).

    [0189] Scheme 2 illustrates a suitable preparation for other compounds of Formula (I).

    ##STR00171##

    With reference to Scheme 2, the chloride starting material is reacted with an excess of amine, or with the amine in the presence of a hindered amine base, such as triethylamine and/or pyridine. Additional methods for synthesizing ester compounds of Formula (I) are known to those of skill in the art and for example in Molecules 2020, 25, 2523 Angewandte Chemie, International Edition 2015, 54, 2849-2853; European Journal of Medicinal Chemistry 1980, 15, 413-418.

    General Procedure A

    ##STR00172##

    Step 1: ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

    ##STR00173##

    [0190] To a solution of 4-fluorophenoxyacetic acid (150 mg, 0.88 mmol, 2.0 eq) in DMF (2 mL) was added ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (100 mg, 0.44 mmol, 1.0 eq), DIEA (172 mg, 1.33 mmol, 3.0 eq) and HATU (202 mg, 1.2 mmol, 2.7 eq). The reaction mixture was stirred at room temperature for 2 hours, and then it was poured into water (10 mL). The resulting solid was collected by filtration and washed with water (5 mL3), then dried under vacuum to give the desired product as a white solid (13 mg, 7.7% yield).

    [0191] NoteDIEA=N,N-Di-isopropylethylamine; HATU=Hexafluorophosphate Azabenzotriazole Tetramethyl Uronium

    [0192] LCMS (Agilent-Acid): Rt: 2.48 min; m/z [M+Na].sup.+=400.1

    [0193] UPLC (Waters-Acid): Rt: 5.65 min, 98.6% purity

    [0194] .sup.1H NMR (400 MHz, DMSO) 11.82 (s, 1H), 7.20 (dd, J=12.0, 5.6 Hz, 2H), 7.14-7.04 (m, 2H), 4.85 (s, 2H), 4.30 (q, J=7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (t, J=7.2 Hz, 3H).

    TABLE-US-00007 TABLE 5 The following compounds were synthesized via the General Procedure A [00174]embedded image [M + H].sup.+ = 392.1 found 392.1 .sup.1H NMR (400 MHz, DMSO) 7.12-7.06 (m, 2H), 6.88-6.77 (m, 2H), 4.54 (s, 2H), 4.22 (d, J = 6.8 Hz, 2H), 3.09 (s, 3H), 2.71 (s, 4H), 1.75 (s, 4H), 1.22 (t, J = 7.2 Hz, 3H). II-2 [00175]embedded image [M + Na].sup.+ = 416.1 found 416.0 .sup.1H NMR (400 MHz, DMSO) 11.80 (s, 1H), 7.41 (d, J = 9.2 Hz, 2H), 7.09 (d, J = 9.2 Hz, 2H), 4.88 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-14 [00176]embedded image [M + Na].sup.+ = 427.1 found 427.0 .sup.1H NMR (400 MHz, DMSO) 11.80 (s, 1H), 8.41-8.16 (m, 2H), 7.33-7.21 (m, 2H), 5.08 (s, 2H), 4.32 (q, J = 7.2 Hz, 2H), 2.73 (s, 2H), 2.63 (s, 2H), 1.74 (s, 4H), 1.31 (t, J = 7.2 Hz, 3H). II-15 [00177]embedded image [M + H].sup.+ = 374.1 found 374.2 .sup.1H NMR (400 MHz, DMSO) 11.81 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 8.4 Hz, 2H), 4.81 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 2.25 (s, 3H), 1.73 (s, 4H), 1.29 (t, J = 7.2 Hz, 3H). II-16 [00178]embedded image [M + H].sup.+ = 390.1 found 390.2 .sup.1H NMR (400 MHz, DMSO) 11.81 (s, 1H), 7.06-6.96 (m, 2H), 6.96-6.87 (m, 2H), 4.78 (s, 2H), 4.29 (q, J = 7.2 Hz, 2H), 3.71 (s, 3H), 2.72 (s, 2H), 2.61 (s, 2H), 1.72 (s, 4H), 1.29 (t, J = 7.2 Hz, 3H). II-17 [00179]embedded image [M + Na].sup.+ = 400.1 found 400.1 .sup.1H NMR (400 MHz, DMSO) 11.80 (s, 1H), 7.39 (dd, J = 15.2, 8.0 Hz, 1H), 7.00- 6.82 (m, 3H), 4.90 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.61 (s, 2H), 1.72 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-18 [00180]embedded image [M + H].sup.+ = 378.1 found 378.1 .sup.1H NMR (400 MHz, DMSO) 11.73 (s, 1H), 7.36-7.20 (m, 2H), 7.15 (t, J = 7.6 Hz, 1H), 7.04 (d, J = 3.6 Hz, 1H), 4.94 (s, 2H), 4.28 (dd, J = 14.0, 6.8 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.72 (s, 4H), 1.28 (t, J = 7.2 Hz, 3H). II-19 [00181]embedded image [M + Na].sup.+ = 418.1 found 418.1 .sup.1H NMR (400 MHz, DMSO) 11.73 (s, 1H), 7.38 (ddd, J = 11.6, 8.8, 3.2 Hz, 1H), 7.29 (td, J = 9.6, 5.6 Hz, 1H), 7.06 (ddd, J = 11.2, 4.0, 2.4 Hz, 1H), 4.93 (s, 2H), 4.28 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.28 (t, J = 7.2 Hz, 3H). II-20 [00182]embedded image [M + Na].sup.+ = 434.1 found 434.0 .sup.1H NMR (400 MHz, DMSO) 11.78 (s, 1H), 7.42 (t, J = 9.2 Hz, 1H), 7.32 (dd, J = 5.2, 2.8 Hz, 1H), 7.15- 7.00 (m, 1H), 4.90 (s, 2H), 4.30 (dd, J = 13.6, 6.8 Hz, 2H), 2.72 (s, 2H), 2.61 (s, 2H), 1.72 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-21 [00183]embedded image [M + Na].sup.+ = 466.1 found 466.1 .sup.1H NMR (400 MHz, DMSO) 11.81 (s, 1H), 7.38 (d, J = 8.8 Hz, 2H), 7.16 (d, J = 9.2 Hz, 2H), 4.91 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.29 (t, J = 7.2 Hz, 3H). II-23 [00184]embedded image [M + H].sup.+ = 404.1 found 404.1 .sup.1H NMR (400 MHz, DMSO) 11.79 (s, 1H), 6.87 (d, J = 8.4 Hz, 1H), 6.77 (d, J = 2.4 Hz, 1H), 6.51 (dd, J = 8.4, 2.4 Hz, 1H), 5.99 (s, 2H), 4.78 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.72 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-22 [00185]embedded image [M + H].sup.+ = 428.1 found 428.1 .sup.1H NMR (400 MHz, DMSO) 11.81 (s, 1H), 7.61 (t, J = 8.0 Hz, 1H), 7.39 (t, J = 6.0 Hz, 3H), 5.00 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-24 [00186]embedded image [M + H].sup.+ = 361.1 found 361.1 .sup.1H NMR (400 MHz, CDCl.sub.3) 12.30 (s, 1H), 8.67 (s, 2H), 7.41 (s, 2H), 4.97 (s, 2H), 4.34 (d, J = 7.2 Hz, 2H), 2.78 (s, 2H), 2.67 (s, 2H), 1.80 (s, 4H), 1.39 (t, J = 7.2 Hz, 3H). II-25 [00187]embedded image [M + H].sup.+ = 361.1 found 361.1 .sup.1H NMR (400 MHz, DMSO) 11.81 (s, 1H), 8.42 (d, J = 2.4 Hz, 1H), 8.26 (d, J = 4.4 Hz, 1H), 7.51 (d, J = 5.6 Hz, 1H), 7.40 (dd, J = 8.4, 4.8 Hz, 1H), 4.98 (s, 2H), 4.31 (q, J = 7.2 Hz, 2H), 2.73 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-26 [00188]embedded image [M + H].sup.+ = 368.1 found 368.1 .sup.1H NMR (400 MHz, DMSO) 11.73 (s, 1H), 4.33-4.21 (m, 4H), 3.90-3.80 (m, 2H), 3.74-3.64 (m, 1H), 3.40-3.34 (m, 2H), 2.72 (s, 2H), 2.61 (s, 2H), 1.95 (d, J = 9.6 Hz, 2H), 1.72 (s, 4H), 1.59-1.47 (m, 2H), 1.30 (t, J = 7.2 Hz, 3H). II-28 [00189]embedded image [M + Na].sup.+ = 398.1 found 398.1 .sup.1H NMR (400 MHz, DMSO) 10.94 (s, 1H), 7.33-7.22 (m, 2H), 7.10 (ddd, J = 8.8, 6.0, 2.4 Hz, 2H), 4.26 (q, J = 7.2 Hz, 2H), 2.91 (t, J = 7.2 Hz, 2H), 2.86-2.78 (m, 2H), 2.69 (s, 2H), 2.58 (s, 2H), 1.71 (s, 4H), 1.29 (t, J = 7.2 Hz, 3H). II-12 [00190]embedded image [M + H].sup.+ = 372.1 found 372.0 .sup.1H NMR (400 MHz, DMSO) 13.28 (s, 1H), 12.13 (s, 1H), 7.24-7.13 (m, 2H), 7.12-7.01 (m, 2H), 4.84 (s, 2H), 2.72 (d, J = 5.6 Hz, 2H), 2.61 (s, 2H), 1.72 (d, J = 5.2 Hz, 4H). II-3 [00191]embedded image [M + H].sup.+ = 364.1 Found 364.0 .sup.1H NMR (400 MHz, DMSO) 11.78 (s, 1H), 7.20 (dd, J = 12.0, 5.6 Hz, 2H), 7.13- 7.04 (m, 2H), 4.85 (s, 2H), 3.83 (s, 3H), 2.72 (d, J = 8.4 Hz, 2H), 2.62 (s, 2H), 1.73 (d, J = 2.4 Hz, 4H). II-4 [00192]embedded image [M + H].sup.+ = 392.1 found 392.1 .sup.1H NMR (400 MHz, DMSO) 11.85 (s, 1H), 7.24-7.16 (m, 2H), 7.09 (ddd, J = 6.8, 5.6, 3.2 Hz, 2H), 5.20-5.09 (m, 1H), 4.85 (s, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (d, J = 6.0 Hz, 6H). II-5 [00193]embedded image [M + Na].sup.+ = 428.1 found 428.1 .sup.1H NMR (400 MHz, DMSO) 11.90 (s, 1H), 7.19 (t, J = 8.8 Hz, 2H), 7.13-7.03 (m, 2H), 4.85 (s, 2H), 2.69 (s, 2H), 2.61 (s, 2H), 1.72 (s, 4H), 1.54 (s, 9H). II-6 [00194]embedded image [M + H].sup.+ = 406.1 found 406.2 .sup.1H NMR (400 MHz, DMSO) 12.01 (s, 1H), 7.22-7.13 (m, 2H), 7.11-7.03 (m, 2H), 4.23 (p, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.63 (s, 2H), 1.73 (d, J = 4.8 Hz, 4H), 1.48 (s, 6H), 1.23 (t, J = 7.2 Hz, 3H). II-7 [00195]embedded image [M + H].sup.+ = 394.1 found 394.1 .sup.1H NMR (400 MHz, DMSO) 11.68 (s, 1H), 7.56-7.32 (m, 2H), 7.18 (dd, J = 12.4, 5.2 Hz, 2H), 4.29 (q, J = 7.2 Hz, 2H), 4.08 (s, 2H), 2.68 (s, 2H), 2.57 (s, 2H), 1.69 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H). II-10 [00196]embedded image [M + H].sup.+ = 380.1 found 380.1 .sup.1H NMR (400 MHz, DMSO) 11.80 (s, 1H), 7.20 (t, J = 8.8 Hz, 2H), 7.14-7.04 (m, 2H), 4.88 (s, 2H), 4.64 (s, 2H), 4.31 (q, J = 7.2 Hz, 2H), 3.85 (t, J = 5.6 Hz, 2H), 2.80 (s, 2H), 1.30 (t, J = 7.2 Hz, 3H). II-29 [00197]embedded image [M + H].sup.+ = 374.1 found 374.1 .sup.1H NMR (400 MHz, DMSO) 12.27 (s, 1H), 8.29 (d, J = 8.4 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 7.37 (t, J = 7.6 Hz, 1H), 7.23 (t, J = 8.8 Hz, 2H), 7.18-7.10 (m, 2H), 4.96 (s, 2H), 4.48 (q, J = 7.2 Hz, 2H), 1.43 (t, J = 7.2 Hz, 3H). II-30 [00198]embedded image [M + H].sup.+ = 402.1 found 402.1 1H NMR (400 MHz, ) 11.56 (s, 1H), 8.11 (dd, J = 8.0, 1.2 Hz, 1H), 7.54 (dd, J = 7.6, 1.2 Hz, 1H), 7.45- 7.30 (m, 2H), 5.04 (s, 2H), 4.24 (q, J = 7.2 Hz, 2H), 2.71 (s, 2H), 2.61 (s, 2H), 2.55 (s, 3H), 1.72 (s, 4H), 1.26 (t, J = 7.2 Hz, 3H). II-37 [00199]embedded image [M + H].sup.+ = 389.1 found 389.1 1H NMR (400 MHz, DMSO) 11.50 (s, 1H), 8.79 (d, J = 4.0 Hz, 1H), 8.26 (d, J = 7.6 Hz, 1H), 8.07 (td, J = 7.6, 1.6 Hz, 1H), 7.72 (ddd, J = 7.6, 4.8, 1.1 Hz, 1H), 5.13 (s, 2H), 4.25 (q, J = 7.2 Hz, 2H), 2.71 (s, 2H), 2.62 (s, 2H), 1.72 (s, 4H), 1.26 (t, J = 7.2 Hz, 3H). II-27

    General Procedure B

    ##STR00200##

    Step 1: ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

    ##STR00201##

    [0195] To a solution of 2-(pyridin-2-yloxy)acetic acid (136 mg, 0.88 mmol, 2.0 eq) in DCM (4 mL), pyridine (246 mg, 3.11 mmol, 7.0 eq) and ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (100 mg, 0.44 mmol, 1.0 eq) were added at 0 C. After stirring for 10 minutes at this temperature, POCl3 (408 mg, 2.66 mmol, 6.0 eq) was introduced. The mixture was then stirred at room temperature for 16 hours. Water (10 mL) was added, and the mixture was extracted with dichloromethane (310 mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude residue was purified by reversed-phase column chromatography (ACN:H2O=8:2) to yield the product as a white solid (84 mg, 50% yield).

    [0196] LCMS (Agilent-Acid): Rt: 2.13 min; m/z [M+H].sup.+=361.1

    [0197] UPLC (Waters-Acid): Rt: 4.14 min, 97.00% purity

    [0198] .sup.1H NMR (400 MHz, DMSO): 11.16 (s, 1H), 7.72 (dd, J=6.8, 1.6 Hz, 1H), 7.50 (ddd, J=8.8, 6.8, 2.0 Hz, 1H), 6.43 (d, J=9.2 Hz, 1H), 6.36-6.24 (m, 1H), 4.89 (s, 2H), 4.27 (q, J=7.2 Hz, 2H), 2.70 (s, 2H), 2.59 (s, 2H), 1.72 (s, 4H), 1.30 (t, J=7.2 Hz, 3H).

    TABLE-US-00008 TABLE 6 The following compounds were synthesized via the General Procedure B [00202]embedded image [M + H].sup.+ = 396.1 found 396.1 .sup.1H NMR (400 MHz, DMSO) 11.83 (s, 1H), 7.30-7.15 (m, 2H), 7.14- 7.04 (m, 2H), 4.87 (s, 2H), 4.31 (q, J = 7.2 Hz, 2H), 3.76 (s, 2H), 2.98 (d, J = 5.2 Hz, 2H), 2.89 (t, J = 5.6 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H). II-40

    General Procedure C

    ##STR00203##

    Step 1: ethyl 2-(2-(pyrimidin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

    ##STR00204##

    [0199] To a solution of 2-(pyrimidin-2-yloxy)acetic acid (50 mg, 0.35 mmol, 1.0 eq) in acetonitrile (2 mL) were added TCFH (136 mg, 0.48 mmol, 1.5 eq) and NMI (80 mg, 0.97 mmol, 3.0 eq). The reaction mixture was stirred at room temperature for 30 minutes. Then, ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (146 mg, 1.1 eq) was added, and the mixture was stirred at room temperature for another 30 minutes. The mixture was poured into water (10 mL), and the resulting solid was collected by filtration. The filter cake was washed with water (35 mL) and dried under vacuum to yield the desired product as a white solid (47 mg, 30% yield).

    [0200] NoteTCFH=N,N,N,N-Tetramethylchloroformamidinium Hexafluorophosphate and NMI=N-Methylimidazole.

    [0201] LCMS (Agilent-Acid): Rt: 2.28 min; m/z [M+H].sup.+=362.1

    [0202] UPLC (Waters-Acid): Rt: 4.82 min, 99.46% purity

    [0203] .sup.1H NMR (400 MHz, DMSO): 11.51 (s, 1H), 8.68 (d, J=4.8 Hz, 2H), 7.25 (t, J=4.8 Hz, 1H), 5.10 (s, 2H), 4.27 (d, J=7.2 Hz, 2H), 2.70 (s, 2H), 2.61 (s, 2H), 1.79-1.65 (m, 4H), 1.29 (t, J=7.2 Hz, 3H).

    General Procedure D

    ##STR00205##

    Step 1: ethyl 2-(2-((4-fluorophenyl)sulfonyl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

    ##STR00206##

    [0204] To a solution of ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (50 mg, 0.12 mmol, 1.0 eq) in DCM (2 mL) was added m-CPBA (88 mg, 0.50 mmol, 4.0 eq, 85% purity). The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was added 10% Na2CO3 (5 mL), extracted with DCM (3*5 mL) dried over Na2SO4, filtered and concentrated. The crude residue was purified by reversed-phase column (ACN:H2O=6/4) to give the product (16 mg, 30% yield) as a white solid.

    [0205] LCMS (Agilent-Acid): Rt: 2.30 min; m/z [M+Na].sup.+=448.0

    [0206] UPLC (Waters-Acid): Rt: 4.98 min, 96.50% purity

    [0207] .sup.1H NMR (400 MHz, DMSO): 11.51 (s, 1H), 8.68 (d, J=4.8 Hz, 2H), 7.25 (t, J=4.8 Hz, 1H), 5.10 (s, 2H), 4.27 (d, J=7.2 Hz, 2H), 2.70 (s, 2H), 2.61 (s, 2H), 1.79-1.65 (m, 4H), 1.29 (t, J=7.2 Hz, 3H).

    TABLE-US-00009 TABLE 7 The following compounds were synthesized via the General Procedure D [00207]embedded image [M + Na].sup.+ = 448.1 found 448.0 .sup.1H NMR (400 MHz, DMSO) 11.25 (s, 1H), 8.03-7.89 (m, 2H), 7.52 (t, J = 8.8 Hz, 2H), 4.95 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.71 (s, 2H), 2.59 (s, 2H), 1.71 (s, 4H), 1.32 (t, J = 7.2 Hz, 3H). II-11 [00208]embedded image [M + Na].sup.+ = 450.1 found 450.0 .sup.1H NMR (400 MHz, DMSO) 11.82 (s, 1H), 7.20 (t, J = 8.8 Hz, 2H), 7.14-7.05 (m, 2H), 4.90 (s, 2H), 4.50 (s, 2H), 4.34 (q, J = 7.2 Hz, 2H), 3.42 (t, J = 6.0 Hz, 2H), 3.33 (s, 2H), 1.32 (t, J = 7.2 Hz, 3H). II-32

    VII. Certain Embodiments

    [0208] The present disclosure contemplates, among other things, the following numbered embodiments:

    [0209] 1. A method for inhibiting apyrase, comprising contacting the apyrase with a compound of the formula

    ##STR00209##

    or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein [0210] Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; [0211] wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; [0212] R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; [0213] R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; [0214] X is (CR.sup.aR.sup.b).sub.nY; [0215] Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; [0216] R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; [0217] each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; [0218] R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)], NR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0219] each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; [0220] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0221] each R.sup.e is independently R.sup.b or R.sup.d; [0222] each m is independently an integer from 0 to 2; and [0223] each n is independently an integer from 0 to 2; provided that the compound is not

    ##STR00210##

    [0224] 2. The method of embodiment 1, wherein the compound has the formula:

    ##STR00211##

    [0225] 3. The method of embodiment 1, wherein the compound has the formula:

    ##STR00212##

    [0226] 4. The method of any one of embodiments 1-3, wherein at least one of Z.sup.1 and Z.sup.2 is hydrogen.

    [0227] 5. The method of any one of embodiments 1-4, wherein Z.sup.1 and Z.sup.2 are both hydrogen.

    [0228] 6. The method of any one of embodiments 1-4, wherein at least one of Z.sup.1 and Z.sup.2 is C.sub.1-6 alkyl.

    [0229] 7. The method of embodiment 1, wherein Z.sup.1 and Z.sup.2 are both C.sub.1-6 alkyl.

    [0230] 8. The method of embodiment 1, wherein Z.sup.1 together with Z.sup.2 forms a 6-membered ring.

    [0231] 9. The method of embodiment 1 or 8, wherein Z.sup.1 and Z.sup.2 together form an aliphatic ring.

    [0232] 10. The method of embodiment 1 or 8, wherein Z.sup.1 and Z.sup.2 together form a heteroaliphatic ring.

    [0233] 11. The method of embodiment 1 or 8, wherein Z.sup.1 and Z.sup.2 together form an aromatic ring.

    [0234] 12. The method of embodiment 1 or 8, wherein Z.sup.1 and Z.sup.2 together form a heteroaromatic ring.

    [0235] 13. The method of any one of embodiments 1-8, wherein Z.sup.1 together with Z.sup.2 forms a ring selected from:

    ##STR00213##

    [0236] 14. The method of any one of embodiments 1, 2, 8, 9 and 13, wherein the compound has the formula:

    ##STR00214##

    [0237] 15. The method of any one of embodiments 1, 3, 8, 9 and 11, wherein the compound has the formula:

    ##STR00215##

    [0238] 16. The method of any one of embodiments 1, 2, 8 and 10, wherein the compound has the formula:

    ##STR00216##

    [0239] 17. The method of any one of embodiments 1, 3, 8 and 10, wherein the compound has the formula:

    ##STR00217##

    [0240] 18. The method of any one of embodiments 1, 2, 8 and 10, wherein the compound has the formula:

    ##STR00218##

    [0241] 19. The method of any one of embodiments 1, 3, 8 and 10, wherein the compound has the formula:

    ##STR00219##

    [0242] 20. The method of any one of embodiments 1, 2, 8, 11 and 13, wherein the compound has the formula:

    ##STR00220##

    [0243] 21. The method of any one of embodiments 1, 3, 8, 11 and 13, wherein the compound has the formula:

    ##STR00221##

    [0244] 22. The method of any one of embodiments 1, 2, 8, 12 and 13, wherein the compound has the formula:

    ##STR00222##

    [0245] 23. The method of any one of embodiments 1, 3, 8, 12 and 13, wherein the compound has the formula:

    ##STR00223##

    [0246] 24. The method of any one of embodiments 1-23, wherein R.sup.1 is hydrogen.

    [0247] 25. The method of any one of embodiments 1-23, wherein R.sup.1 is C.sub.1-6 alkyl.

    [0248] 26. The method of any one of embodiments 1-23, wherein R.sup.1 is C.sub.1-6 alkyl substituted with one or more R.sup.a.

    [0249] 27. The method of any one of embodiments 1-26, wherein R.sup.2 is hydrogen.

    [0250] 28. The method of any one of embodiments 1-26, wherein R.sup.2 is C.sub.1-6 alkyl.

    [0251] 29. The method of any one of embodiments 1-28, wherein Y is selected from the group consisting of

    ##STR00224## ##STR00225## ##STR00226##

    [0252] 30. The method of embodiment 1, wherein the compound is selected from the group consisting of: [0253] ethyl 2-(3-(N-(3-chlorophenyl)sulfamoyl)benzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0254] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl pyrazine-2-carboxylate [0255] 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl picolinate [0256] ethyl 2-(2-(phenylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0257] ethyl 2-(2-(cyclohexyl(methyl)amino)acetamido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate [0258] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethylisonicotinate [0259] 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate [0260] ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0261] ethyl 2-(2-(o-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0262] ethyl 2-(2-(tert-butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0263] isopropyl 2-(2-((4-hydroxy-6-oxo-1-propyl-1,6-dihydropyrimidin-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0264] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(1H-pyrazol-1-yl)nicotinate [0265] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2-carboxylate [0266] isopropyl 2-(2-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0267] ethyl 2-(2-(quinolin-8-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0268] ethyl 2-(2-(4-methoxyphenoxy)acetamido)thiophene-3-carboxylate [0269] isopropyl 2-(2-((4-oxo-4-(thiophen-2-yl)butanoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0270] isopropyl 2-(2-((5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0271] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(tert-butyl)-1,2,3,4-tetrahydroacridine-9-carboxylate [0272] ethyl 2-(2-cyclopentylacetamido)-4,5-dimethylthiophene-3-carboxylate [0273] isopropyl 2-(2-((5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0274] ethyl 2-(2-(3-fluorophenoxy)acetamido)thiophene-3-carboxylate [0275] ethyl 2-(2-(thieno[2,3-d]pyrimidin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0276] ethyl 2-(2-phenylacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0277] isopropyl 2-(2-(2-((methylsulfonyl)methyl)-1H-benzo[d]imidazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0278] ethyl 2-(2-(benzo[d]oxazol-2-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0279] isopropyl 2-(2-((4-(2-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0280] isopropyl 2-(2-((3-(4-methyl-2-oxothiazol-3(2H)-yl)propanoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0281] tert-butyl 2-(3-bromoisonicotinamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0282] isopropyl 2-(2-((5-amino-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0283] ethyl 2-(2-(naphthalen-2-yloxy)acetamido)thiophene-3-carboxylate [0284] isopropyl 2-(2-((1-(3-fluorophenyl)cyclopentane-1-carbonyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0285] isopropyl 2-(2-(6,7-dimethoxy-4-oxoquinazolin-3(4H)-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0286] isopropyl 2-(5-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)furan-2-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0287] isopropyl 2-(2-((4-amino-5-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0288] isopropyl 6-methyl-2-(5-methylpyrazine-2-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0289] ethyl 2-(2-((4-fluorophenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0290] tert-butyl 6,6-dimethyl-2-(2-(methylsulfonyl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0291] ethyl 2-(2-(methyl(phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0292] tert-butyl 2-(2-(1H-pyrazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0293] ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate [0294] isopropyl 2-(1-methyl-1H-1,2,3-triazole-5-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0295] tert-butyl 2-(2-(4-oxopyrazolo[1,5-d][1,2,4]triazin-5(4H)-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0296] tert-butyl 2-(2-ethoxyacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0297] ethyl 4,5-dimethyl-2-(2-(phenylthio)acetamido)thiophene-3-carboxylate [0298] isopropyl 2-(2-((4-methoxybenzyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0299] oxalic acid salt of isopropyl 2-(2-((3-hydroxypropyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0300] 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylisoxazole-4-carboxylate [0301] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate [0302] isopropyl 2-(2-((4-allyl-5-methyl-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0303] ethyl 2-(2-((2-methoxyphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate [0304] ethyl 2-(2-((5-methyl-1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0305] ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate [0306] ethyl 2-(2-(3-cyanophenoxy)acetamido)thiophene-3-carboxylate [0307] ethyl 2-(2-((5-amino-1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0308] ethyl 4,5-dimethyl-2-(3-(phenylthio)propanamido)thiophene-3-carboxylate [0309] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5-methylpyrazine-2-carboxylate [0310] ethyl 2-(2-((1,3,4-thiadiazol-2-yl)thio)acetamido)thiophene-3-carboxylate [0311] ethyl 2-(2-(quinazolin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0312] tert-butyl 2-(1-acetylpyrrolidine-3-carboxamido)-6,6-dimethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0313] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2,5-dimethylfuran-3-carboxylate [0314] oxalic acid salt of isopropyl 2-(2-(4-methylpiperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0315] tert-butyl 2-(2-oxo-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0316] isopropyl 2-(2-(4-(furan-2-carbonyl)piperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0317] oxalic acid salt of isopropyl 2-(2-(ethylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0318] ethyl 4,5-dimethyl-2-(2-(thiophen-2-yl)acetamido)thiophene-3-carboxylate [0319] isopropyl 2-(2-(2-(4-oxo-3,4-dihydrophthalazin-1-yl)acetoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0320] isopropyl 2-(2-(1H-1,2,4-triazol-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0321] ethyl 2-(2-(naphthalen-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0322] ethyl 2-(2-(p-tolylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0323] ethyl 2-(2-(adamantan-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0324] ethyl 2-(2-((5-amino-4H-1,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0325] 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate [0326] isopropyl 6-methyl-2-(2-(4-(4-nitrophenyl)piperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0327] 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl isonicotinate [0328] 1-(2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl)cyclopentane-1-carboxylic acid [0329] ethyl 2-(2-((1-methyl-1H-tetrazol-5-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0330] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-hydroxyquinoline-4-carboxylate [0331] ethyl 2-(2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0332] ethyl 2-(3-morpholinopropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0333] 4-((2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethoxy)carbonyl)pyridine 1-oxide [0334] ethyl 2-(3-(pyrrolidin-1-yl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt [0335] 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate [0336] ethyl 2-(2-(1-methyl-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl)acetamido)thiophene-3-carboxylate [0337] ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate [0338] ethyl 2-acetamido-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0339] ethyl 2-(2-cyanoacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0340] ethyl 4,5-dimethyl-2-(2-(m-tolylamino)acetamido)thiophene-3-carboxylate [0341] ethyl 2-(4-methoxy-4-oxobutanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0342] 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl pyrazine-2-carboxylate [0343] ethyl 2-(2-(cycloheptylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0344] ethyl 2-(2-((3,5-dimethylphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate [0345] ethyl 2-(2-((2,6-difluorobenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0346] ethyl 4,5-dimethyl-2-(2-(o-tolyloxy)acetamido)thiophene-3-carboxylate [0347] 2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(allylamino)thiazole-4-carboxylate [0348] 2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl picolinate [0349] ethyl 2-(2-(benzoyloxy)acetamido)-4,5-dimethylthiophene-3-carboxylate [0350] ethyl 2-(2-((4-(methoxycarbonyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0351] ethyl 2-(2-(benzylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0352] ethyl 2-(2-((1-methyl-4,5-dihydro-1H-imidazol-2-yl)thio)acetamido)thiophene-3-carboxylate [0353] ethyl 2-(2-(azepan-1-yl)acetamido)-4,5-dimethylthiophene-3-carboxylate [0354] ethyl 2-(2-((4-chlorobenzyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0355] ethyl 2-(2-((1,3,4-thiadiazol-2-yl)thio)acetamido)-4,5-dimethylthiophene-3-carboxylate [0356] oxalic acid salt of ethyl 2-(2-(butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0357] ethyl 2-(2-((3-(trifluoromethyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0358] ethyl 2-(2-(2,6-dimethylmorpholino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0359] ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0360] ethyl 2-(2-(4-fluorophenoxy)-N-methylacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0361] 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid [0362] methyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0363] isopropyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0364] tert-butyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0365] ethyl 2-(2-(4-fluorophenoxy)-2-methylpropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0366] ethyl 2-(2-((4-fluorophenyl)(methyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0367] ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0368] ethyl 2-(2-((4-fluorophenyl)sulfonyl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0369] ethyl 2-(3-(4-fluorophenyl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0370] ethyl 2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0371] ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0372] ethyl 2-(2-(4-nitrophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0373] ethyl 2-(2-(p-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0374] ethyl 2-(2-(4-methoxyphenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0375] ethyl 2-(2-(3-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0376] ethyl 2-(2-(2-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0377] ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0378] ethyl 2-(2-(3-chloro-4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0379] ethyl 2-(2-(benzo[d][1,3]dioxol-5-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0380] ethyl 2-(2-(4-(trifluoromethoxy)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0381] ethyl 2-(2-(3-(trifluoromethyl)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0382] ethyl 2-(2-(pyridin-4-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0383] ethyl 2-(2-(pyridin-3-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0384] ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0385] ethyl 2-(2-((tetrahydro-2H-pyran-4-yl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0386] ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate [0387] ethyl 2-(2-(4-fluorophenoxy)acetamido)benzo[b]thiophene-3-carboxylate [0388] ethyl 2-(2-(4-fluorophenoxy)acetamido)-5-methyl-4-oxo-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate [0389] ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate 6,6-dioxide [0390] ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]pyran-3-carboxylate [0391] ethyl 2-(2-phenoxyacetamido)benzo[b]thiophene-3-carboxylate [0392] ethyl 5-methyl-4-oxo-2-(2-phenoxyacetamido)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate [0393] ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]thiopyran-3-carboxylate 5,5-dioxide [0394] ethyl 2-(2-((2-methylbenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0395] ethyl 2-(2-(pyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate [0396] ethyl 2-(2-(N-methylpyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate; and [0397] ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate,
    or a combination thereof.

    [0398] 31. The method of any one of embodiments 1-30, wherein contacting the apyrase comprises treating a crop with the compound.

    [0399] 32. The method of embodiment 31, further comprising treating the crop with a pesticide.

    [0400] 33. The method of embodiment 32, wherein the pesticide is selected from acaricides, fungicides, herbicides, insecticides, molluscicides, nematocides, or a combination thereof.

    [0401] 34. The method of embodiment 33, wherein the pesticide comprises a fungicide.

    [0402] 35. The method of embodiment 34, further comprising treating the crop with a fungicide selected from selected from benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.

    [0403] 36. A composition, comprising [0404] a fungicide; [0405] a compound of the formula

    ##STR00227## [0406] or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein [0407] Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; [0408] wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; [0409] R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; [0410] R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; [0411] X is (CR.sup.aR.sup.b).sub.nY; [0412] Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; [0413] R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; [0414] each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; [0415] R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0416] each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; [0417] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0418] each R.sup.e is independently R.sup.b or R.sup.d; [0419] each m is independently an integer from 0 to 2; and [0420] each n is independently an integer from 0 to 2; and [0421] a phytologically acceptable carrier.

    [0422] 37. The composition of embodiment 36, wherein the composition comprises from about 1 to about 80 weight percent of the compound.

    [0423] 38. The composition of embodiment 37, wherein the composition is a suspension formulation.

    [0424] 39. The composition of embodiment 37, wherein the composition comprises from about 1 to about 50 weight percent of the compound.

    [0425] 40. The composition of embodiment 39, further comprising sodium polycarboxylate.

    [0426] 41. The composition of embodiment 40, further comprising biocides.

    [0427] 42. The composition of embodiment 41, further comprising organosilicone antifoam emulsion.

    [0428] 43. The composition of embodiment 42, wherein the composition is a wettable powder.

    [0429] 44. The composition of embodiment 43, wherein the composition is an emulsifiable concentrate.

    [0430] 45. The composition of embodiment 44, further comprising tristyrylphenol ethoxylates.

    [0431] 46. The composition of embodiment 36, wherein the composition is an oil dispersible concentrate.

    [0432] 47. A pesticidal composition, comprising [0433] a pesticide; [0434] a compound of the formula

    ##STR00228## [0435] or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein [0436] Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; [0437] wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; [0438] R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; [0439] R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; [0440] X is (CR.sup.aR.sup.b).sub.nY; [0441] Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; [0442] R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; [0443] each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-s cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; [0444] R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)], NR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0445] each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; [0446] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0447] each R.sup.e is independently R.sup.b or R.sup.d; [0448] each m is independently an integer from 0 to 2; and [0449] each n is independently an integer from 0 to 2; and [0450] a phytologically acceptable carrier.

    [0451] 48. The pesticidal composition of embodiment 47, wherein the pesticide comprises an acaricide, fungicide, herbicide, insecticide, molluscicide, nematocide, or a combination thereof.

    [0452] 49. A fungicidal composition, comprising [0453] a fungicide; [0454] a compound of the formula

    ##STR00229## [0455] or an agriculturally acceptable salt, solvate and/or N-oxide thereof, wherein [0456] Z.sup.1 and Z.sup.2 are each independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl; or Z.sup.1 together with Z.sup.2 and the atoms to which Z.sup.1 and Z.sup.2 are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a; [0457] wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, N(R.sup.e), S, S(O), SO.sub.2; [0458] R.sup.1 is independently selected from a group consisting of hydrogen, C.sub.1-6 alkyl, optionally substituted with one or more R.sup.a; [0459] R.sup.2 is selected from hydrogen and C.sub.1-6 alkyl; [0460] X is (CR.sup.aR.sup.b).sub.nY; [0461] Y is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.8, R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; S(O)R.sup.8, S(O).sub.2R.sup.8, N(R.sup.d)S(O).sub.2R.sup.8, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, C(O)OR.sup.8, C(O)R.sup.8, OC(O)R.sup.8, C(O)NR.sup.cR.sup.c, NR.sup.cR.sup.c, N(R.sup.d)C(O)R.sup.8, N(R.sup.d)C(O)OR.sup.8, N(R.sup.d)C(O)NR.sup.cR.sup.c, SR.sup.8, (CH.sub.2).sub.mR.sup.8, OC(O)(CH.sub.2).sub.mC(O)R.sup.8, CHR.sup.cR.sup.c; [0462] R.sup.8 is selected from the group consisting of R.sup.a, R.sup.b, R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, CH.sub.2R.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b; [0463] each R.sup.a is independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; [0464] R.sup.b is independently selected from the group consisting of O, OR.sup.a, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, N(H)S(O).sub.2R.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)], R.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)], OR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)], NR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0465] each R.sup.c is hydrogen, R.sup.8, or, alternatively, two R.sup.c are taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different R.sup.e groups; [0466] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0467] each R.sup.e is independently R.sup.b or R.sup.d; [0468] each m is independently an integer from 0 to 2; and [0469] each n is independently an integer from 0 to 2; and [0470] a phytologically acceptable carrier.

    [0471] 50. The composition of embodiment 49, wherein the fungicide is selected from the group consisting of benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors, triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.

    TABLE-US-00010 APPENDIX 1 TARGET SITE CHEMICALOR MOA AND CODE GROUP NAME BIOLOGICAL GROUP A: A1 PA - fungicides acylalanines nucleic RNA polymerase I (PhenylAmides) oxazolidinones acids butyrolactones metabolism A2 hydroxy- hydroxy- adenosin- (2-amino-) (2-amino-) deaminase pyrimidines pyrimidines A3 heteroaromatics isoxazoles DNA/RNA synthesis isothiazolones (proposed) A4 carboxylic acids carboxylic acids DNA topoisomerase type II (gyrase) A5 DHODHI- phenyl-propanol inhibition of fungicides dihydroorotate dehydrogenase within de novo pyrimidine biosynthesis B: B1 MBC - benzimidazoles Cytoskeleton tubulin fungicides thiophanates and motor polymerization (Methyl protein Benzimidazole Carbamates) B2 N-phenyl N-phenyl tubulin carbamates carbamates polymerization B3 benzamides toluamides tubulin thiazole ethylamino-thiazole- polymerization carboxamide carboxamide B4 phenylureas phenylureas cell division (unknown site) B5 benzamides pyridinylmethyl- delocalisation of benzamides spectrin-like proteins B6 cyanoacrylates aminocyano acrylates actin/myosin/fimbrin aryl-phenyl- benzophenone function ketones benzoylpyridine B7 pyridazine pyridazine tubulin dynamics modulator C. C1 pyrimidinamines pyrimidinamines respiration complex | NADH pyrazole-MET1 pyrazole-5- oxido-reductase carboxamides Quinazoline quinazoline C2 SDHI phenyl-benzamides complex II: (Succinate- phenyl-oxo-ethyl succinate-dehydro- dehydrogenase thiophene amide genase inhibitors) pyridinyl-ethyl- benzamides phenyl-cyclobutyl- pyridineamide furan- carboxamides oxathiin- carboxamides thiazole- carboxamides pyrazole-4- carboxamides N-cyclopropyl-N- benzyl-pyrazole- carboxamides N-methoxy-(phenyl- ethyl)-pyrazole- carboxamides pyridine- carboxamides pyrazine- carboxamides C. C3 QoI-fungicides methoxy-acrylates respiration complex III: (Quinone outside methoxy-acetamide cytochrome bc1 Inhibitors) methoxy-carbamates (ubiquinol oxidase) oximino-acetates at Qo site (cyt b oximino-acetamides gene) oxazolidine-diones dihydro-dioxazines imidazolinones benzyl-carbamates QoI-fungicides tetrazolinones (Quinone outside Inhibitors; Subgroup A) C: C4 QiI - fungicides cyano-imidazole respiration complex III: (Quinone inside sulfamoyl-triazole (continued) cytochrome bc1 Inhibitors) picolinamides (ubiquinone reductase) at Qi site C5 dinitrophenyl- uncouplers of crotonates oxidative phos- 2,6-dinitro-anilines phorylation (pyr.-hydrazones) C6 organo tin tri-phenyl tin inhibitors of compounds compounds oxidative phos- phorylation, ATP synthase C7 thiophene- thiophene- ATP transport carboxamides carboxamides (proposed) C8 QoSI fungicides triazolo-pyrimidylamine complex III: (Quinone outside cytochrome bc1 Inhibitor, (ubiquinone stigmatellin reductase) at binding type) Qo site, stigmatellin binding sub-site D: D1 AP - fungicides anilino-pyrimidines amino acids methionine (Anilino- and protein biosynthesis Pyrimidines) synthesis (proposed) (cgs gene) D2 enopyranuronic enopyranuronic acid protein synthesis acid antibiotic antibiotic (ribosome, termination step) D3 hexopyranosyl hexopyranosyl protein synthesis antibiotic antibiotic (ribosome, initiation step) D4 glucopyranosyl glucopyranosyl protein synthesis antibiotic antibiotic (ribosome, initiation step) D5 tetracycline tetracycline antibiotic protein synthesis antibiotic (ribosome, elongation step) E: E1 aza- aryloxyquinoline signal signal transduction naphthalenes quinazolinone transduction (mechanism unknown) E2 PP-fungicides phenylpyrroles MAP/Histidine- (PhenylPyrroles) Kinase in osmotic signal transduction (os-2, HOG1) E3 dicarboximides dicarboximides MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1) F: F1 formerly dicarboximides lipid F2 phosphoro- phosphoro-thiolates synthesis or phospholipid thiolates transport / biosynthesis, Dithiolanes dithiolanes membrane methyltransferase integrity or F3 AH-fungicides aromatic hydrocarbons function cell peroxidation (Aromatic (proposed) Hydrocarbons) (chlorophenyls, nitroanilines) heteroaromatics 1,2,4-thiadiazoles F4 Carbamates carbamates cell membrane permeability, fatty acids (proposed) F5 formerly CAA-fungicides F6 formerly Bacillus amyloliquefaciens strains (FRAC Code 44); microbial disrupters reclassified to BM02 in 2020 of pathogen cell membranes F7 formerly extract from Melaleuca alternifolia (tea tree oil) cell membrane and plant oils (eugenol, geraniol, thymol) disruption FRAC Code 46, reclassified to BM01 in 2021 F8 Polyene amphoteric macrolide ergosterol binding antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis F9 OSBPI piperidinyl-thiazole- lipid homeostasis oxysterol binding isoxazolines and transfer/storage protein homologue inhibition F10 protein fragment polypeptide interaction with lipid fraction of the cell membrane, with multiple effects on cell membrane integrity G: G1 DMI-fungicides piperazines sterol C14- demethylase (DeMethylation pyridines biosynthesis in sterol Inhibitors) pyrimidines in membranes biosynthesis (SBI: Class I) imidazoles (erg11/cyp51) triazoles triazolinthiones G2 amines morpholines .sup.14-reductase (morpholines) piperidines and .sup.8.fwdarw..sup.7- (SBI: Class II) spiroketal-amines isomerase in sterol biosynthesis (erg24, erg2) G3 KRI fungicides hydroxyanilides 3-keto reductase, (KetoReductase amino-pyrazolinone C4- de-methylation Inhibitors) (erg27) (SBI: Class III) G4 thiocarbamates squalene-epoxidase (SBI class IV) allylamines in sterol biosynthesis (erg1) H: H3 Formerly glucopyranosyl cell wall antibiotic (validamycin) biosynthesis H4 polyoxins peptidyl pyrimidine chitin synthase nucleoside H5 CAA-fungicides cinnamic acid amides cellulose synthase (Carboxylic Acid valinamide Amides) carbamates mandelic acid amides I: I1 MBI-R isobenzo-furanone melanin reductase in (Melanin pyrrolo-quinolinone synthesis melanin Biosynthesis triazolobenzo- in cell wall biosynthesis Inhibitors - thiazole Reductase) I2 MBI-D cyclopropane- dehydratase in (Melanin carboxamide melanin Biosynthesis carboxamide biosynthesis Inhibitors - propionamide Dehydratase) I3 MBI-P trifluoroethyl- polyketide synthase (Melanin carbamate in melanin Biosynthesis biosynthesis Inhibitors - Polyketide synthase) P: P 01 benzo- benzo-thiadiazole host plant salicylate-related thiadiazole (BTH) defence (BTH) induction P 02 benzisothiazole benzisothiazole salicylate-related P 03 thiadiazole- thiadiazole- salicylate-related carboxamide carboxamide P 04 natural polysaccharides polysaccharide compound elicitors P 05 plant extract complex mixture, anthraquinone ethanol extract elicitors (anthraquinones, resveratrol) P 06 microbial bacterial microbial elicitors Bacillus spp. fungal Saccharomyces spp. P 07 phosphonates ethyl phosphonates phosphonates P 08 isothiazole isothiazolylmethyl salicylate-related ether U: unknown cyanoacetamide- cyanoacetamide- Unknown mode oxime oxime of action formerly phosphonates (FRAC code 33), reclassified to P 07 in 2018 (U numbers unknown phthalamic acids phthalamic acids not unknown benzotriazines benzotriazines appearing unknown benzene- benzene- in the list sulfonamides sulphonamides derive from unknown pyridazinones pyridazinones reclassified formerly methasulfocarb (FRAC code 42), reclassified to M 12 in 2018 fungicides) unknown phenyl- phenyl-acetamide acetamide cell membrane guanidines guanidines disruption (proposed) unknown thiazolidine cyano-methylene- thiazolidines unknown pyrimidinone- pyrimidinone- hydrazones hydrazones complex III: 4-quinolyl- 4-quinolyl-acetates cytochrome bc1, acetate unknown binding site (proposed) Unknown tetrazolyloxime tetrazolyloximes Unknown glucopyranosyl glucopyranosyl (Inhibition of antibiotic antibiotics trehalase) Not Unknown diverse diverse specified M: multi-site inorganic inorganic Chemicals contact (electrophiles) with activity inorganic inorganic multi-site (electrophiles) activity dithiocarbamates dithio-carbamates and relatives and relatives (electrophiles) phthalimides phthalimides (electrophiles) chloronitriles chloronitriles (phthalonitriles) (phthalonitriles) (unspecified mechanism) sulfamides sulfamides (electrophiles) bis-guanidines bis-guanidines (membrane disruptors, detergents) triazines triazines (unspecified mechanism) quinones quinones (anthraquinones) (anthraquinones) (electrophiles) quinoxalines quinoxalines (electrophiles) maleimide maleimide (electrophiles) thiocarbamate thiocarbamate (electrophiles) BM: multiple effects on plant extract polypeptide (lectin) Biologicals ion membrane with transporters; multiple chelating effects modes of affects fungal plant extract phenols, action: spores and germ sesquiterpenes, Plant tubes, triterpenoids, extracts induced plant coumarins defense cell membrane plant extract terpene hydrocarbons, disruption, cell wall, terpene alcohols and induced plant terpene phenols defense mechanisms BM: multiple effects microbial fungal Biologicals described (strains of living Trichoderma spp. with (examples, not all microbes or fungal multiple apply to all extract, Clonostachys spp. modes of biological groups): metabolites) fungal action: competition, Coniothyrium spp. Microbial mycoparasitism, fungal (living antibiosis, Hanseniaspora spp. microbes, membrane fungal extracts or disruption by Talaromyces spp. metabolites) fungicidal fungal lipopeptides, Saccharomyces spp. lytic enzymes, bacterial induced plant Bacillus spp. defence bacterial Erwinia spp. (peptide) bacterial Gluconobacter spp. bacterial Pseudomonas spp. bacterial Streptomyces spp. FRAC MOA COMMON NAME COMMENTS CODE A: benalaxyl Resistance and cross resistance 4 nucleic benalaxyl-M well known in various acids (=kiralaxyl) Oomycetes but mechanism metabolism furalaxyl unknown. metalaxyl High risk. metalaxyl-M See FRAC Phenylamide (=mefenoxam) Guidelines for resistance oxadixyl management ofurace bupirimate Medium risk. Resistance and 8 dimethirimol cross resistance known in ethirimol powdery mildews. Resistance management required. hymexazole Resistance not known. 32 octhilinone oxolinic acid Bactericide. Resistance known. 31 Risk in fungi unknown. Resistance management required. ipflufenoquin Medium to high risk. 52 B: benomyl Resistance common in many 1 Cytoskeleton carbendazim fungal species. Several target and motor fuberidazole site mutations, mostly protein thiabendazole E198A/G/K, F200Y in -tubulin thiophanate gene. thiophanate-methy Positive cross resistance between the group members. Negative cross resistance to N-phenyl carbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management. diethofencarb Resistance known. Target site 10 mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required. zoxamide Low to medium risk. 22 ethaboxam Resistance management required. pencycuron Resistance not known. 20 fluopicolide Resistant isolates detected in 43 fluopimomide grapevine downy mildew. Medium risk. Resistance management required phenamacril Resistance known in Fusarium 47 graminearum. Target site mutations in the gene coding for myosin-5 found in lab studies. Medium to high risk. Resistance management required. metrafenone Less sensitive isolates detected 50 pyriofenone in powdery mildews (Blumeria and Sphaerotheca) Medium risk. Resistance management required. Reclassified from U8 in 2018 pyridachlometyl High risk. 53 C. diflumetorim Resistance not known. 39 respiration tolfenpyrad fenazaquin benodanil Resistance known for several 7 flutolanil fungal species in field mepronil populations and lab mutants. isofetamid Target site mutations in sdh fluopyram gene, e.g. H/Y (or H/L) at 257, cyclobutrifluram 267, 272 or P225L, dependent fenfuram on fungal species. carboxin Resistance management oxycarboxin required. thifluzamide Medium to high risk. benzovindiflupyr See FRAC SDHI Guidelines bixafen for resistance management. fluindapyr fluxapyroxad furametpyr inpyrfluxam isopyrazam penflufen penthiopyrad sedaxane isoflucypram pydiflumetofen boscalid pyraziflumid C. azoxystrobin Resistance known in various 11 respiration coumoxystrobin fungal species. Target site enoxastrobin mutations in cyt b gene (G143A, flufenoxystrobin F129L) and additional picoxystrobin mechanisms. pyraoxystrobin Cross resistance shown mandestrobin between all members of the pyraclostrobin Code 11 fungicides. pyrametostrobin High risk. triclopyricarb See FRAC QoI Guidelines kresoxim-methyl for resistance management. trifloxystrobin dimoxystrobin fenaminstrobin metominostrobin orysastrobin famoxadone fluoxastrobin fenamidone pyribencarb metyltetraprole Resistance not known. Not .sup.11A cross resistant with Code 11 fungicides on G143A mutants. High risk. See FRAC QoI Guidelines for resistance management. C: cyazofamid Resistance risk unknown but 21 respiration amisulbrom assumed to be medium to high (continued) fenpicoxamid (mutations at target site known florylpicoxamid in model organisms). Resistance management required. No spectrum overlap with the Oomycete-fungicides cyazofamid and amisulbrom binapacryl Resistance not known. 29 meptyldinocap Also acaricidal activity. dinocap fluazinam Low risk. However, resistance claimed in Botrytis in Japan. (ferimzone) Reclassified to U 14 in 2012. fentin acetate Some resistance cases 30 fentin chloride known. Low to medium risk. fentin hydroxide silthiofam Resistance reported. Risk low. 38 ametoctradin Not cross resistant to QoI 45 fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required. D: cyprodinil Resistance known in Botrytis 9 amino acids mepanipyrim and Venturia, sporadically in and protein pyrimethanil Oculimacula. synthesis Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management. blasticidin-S Low to medium risk. 23 Resistance management required. kasugamycin Resistance known in fungal 24 and bacterial (P. glumae) pathogens. Medium risk. Resistance management required. streptomycin Bactericide. Resistance 25 known. High risk. Resistance management required. oxytetracycline Bactericide. Resistance 41 known. High risk. Resistance management required. E: quinoxyfen Resistance to quinoxyfen 13 signal proquinazid known. transduction Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis. fenpiclonil Resistance found sporadically, 12 fludioxonil mechanism speculative. Low to medium risk. Resistance management required. chlozolinate Resistance common in Botrytis 2 dimethachlone and some other pathogens. iprodione Several mutations in OS-1, procymidone mostly I365S. vinclozolin Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management F: formerly dicarboximides lipid edifenphos Resistance known in specific 6 synthesis or iprobenfos (IBP) fungi. transport / pyrazophos Low to medium risk. membrane isoprothiolane Resistance management integrity or required if used for risky function pathogens. biphenyl Resistance known in some 14 chloroneb fungi. dicloran Low to medium risk. quintozene (PCNB) Cross resistance patterns tecnazene (TCNB) complex due to different tolclofos-methyl activity spectra. etridiazole iodocarb Low to medium risk. 28 propamocarb Resistance management prothiocarb required. formerly CAA-fungicides formerly Bacillus amyloliquefaciens strains (FRAC Code 44); reclassified to BM02 in 2020 formerly extract from Melaleuca alternifolia (tea tree oil) and plant oils (eugenol, geraniol, thymol) FRAC Code 46, reclassified to BM01 in 2021 natamycin Resistance not known. 48 (pimaricin) Agricultural, food and topical medical uses. oxathiapiprolin Resistance risk assumed to be 49 fluoxapiprolin medium to high (single site inhibitor). Resistance management required. (Previously U15). polypeptide Resistance not known. 51 ASFBIOF01-02 G: triforine There are big differences in 3 sterol pyrifenox the activity spectra of DMI biosynthesis pyrisoxazole fungicides. in membranes fenarimol Resistance is known in various nuarimol fungal species. Several imazalil resistance mechanisms are oxpoconazole known incl. target site pefurazoate mutations in cyp51 (erg 11) prochloraz gene, e.g. V136A, Y137F, triflumizole A379G, I381V; cyp51 azaconazole promotor; ABC transporters bitertanol and others. bromuconazole Generally wise to accept that cyproconazole cross resistance is present difenoconazole between DMI fungicides active diniconazole against the same fungus. epoxiconazole DMI fungicides are Sterol etaconazole Biosynthesis Inhibitors (SBIs), fenbuconazole but show no cross resistance fluquinconazole to other SBI classes. flusilazole Medium risk. flutriafol See FRAC SBI Guidelines hexaconazole for resistance management. imibenconazole ipconazole mefentrifluconazole metconazole myclobutanil penconazole propiconazole simeconazole tebuconazole tetraconazole triadimefon triadimenol triticonazole prothioconazole aldimorph Decreased sensitivity for 5 dodemorph powdery mildews. fenpropimorph Cross resistance within the tridemorph group generally found but not fenpropidin to other piperalin SBI classes. spiroxamine Low to medium risk. See FRAC SBI Guidelines for resistance management fenhexamid Low to medium risk. 17 fenpyrazamine Resistance management required. pyributicarb Resistance not known, fungicidal and herbicidal activity. naftifine Medical fungicides only. 18 terbinafine H: Formerly glucopyranosyl reclassified to U18 26 cell wall antibiotic (validamycin) biosynthesis polyoxin Resistance known. 19 Medium risk. Resistance management required. dimethomorph Resistance known in 40 flumorph Plasmopara viticola but not in pyrimorph Phytophthora infestans. benthiavalicarb Cross resistance between all iprovalicarb members of the CAA group. valifenalate Low to medium risk. mandipropamid See FRAC CAA Guidelines for resistance management. I: fthalide Resistance not known. 16.1 melanin pyroquilon synthesis tricyclazole in cell wall carpropamid Resistance known. 16.2 diclocymet Medium risk. fenoxanil Resistance management required. tolprocarb Resistance not known. 16.3 Additional activity against bacteria and fungi through induction of host plant defence P: acibenzolar-S-methyl Resistance not known. P 01 host plant probenazole Resistance not known. P 02 defence (also antibacterial and induction antifungal activity) tiadinil Resistance not known. P 03 isotianil laminarin Resistance not known. P 04 extract from Reynoutria Resistance not known. P 05 sachalinensis (giant knotweed) Bacillus mycoides Resistance not known. P 06 isolate J cell walls of Saccharomyces cerevisiae strain LAS117 fosetyl-Al Few resistance cases P07 phosphorous acid and reported in few salts pathogens. Low risk. Reclassified from U33 in 2018 dichlobentiazox activates SAR both up- P 08 and downstream of SA. Resistance not known. U: cymoxanil Resistance claims described. 27 Unknown mode Low to medium risk. of action Resistance management (U numbers required. not formerly phosphonates (FRAC code 33), reclassified to P 07 in 2018 appearing tecloftalam Resistance not known. 34 in the list (Bactericide) derive from triazoxide Resistance not known. 35 reclassified flusulfamide Resistance not known. 36 fungicides) diclomezine Resistance not known. 37 formerly methasulfocarb (FRAC code 42), reclassified to M 12 in 2018 cyflufenamid Resistance in Sphaerotheca. U 06 Resistance management required dodine Resistance known in U 12 Venturia inaequalis. Low to medium risk. Resistance management recommended. flutianil Resistance in Sphaerotheca and U 13 Podosphaera xanthii Resistance management required. ferimzone Resistance not known U 14 (previously C5). tebufloquin Not cross resistant to QoI. U 16 Resistance risk unknown but assumed to be medium. Resistance management required. picarbutrazox Resistance not known. U 17 Not cross resistant to PA, QoI, CAA. validamycin Resistance not known. U 18 Induction of host plant defense by trehalose proposed (previously H3). Not mineral oils, Resistance not known. NC specified organic oils, inorganic salts, material of biological origin M: copper Also applies to organic copper M 01 Chemicals (different salts) complexes with sulphur generally considered as a low M 02 multi-site amobam risk group without any signs of activity ferbam resistance developing to the M 03 mancozeb fungicides. maneb reclassified from U42 in 2018 metiram propineb thiram zinc thiazole zineb ziram captan M 04 captafol folpet chlorothalonil M 05 dichlofluanid M 06 tolylfluanid guazatine M 07 iminoctadine anilazine M 08 dithianon M 09 chinomethionat/ M 10 quinomethionate fluoroimide M 11 methasulfocarb M 12 BM: extract from the Resistance not known. BM 01 Biologicals cotyledons of (previously M12). with lupine plantlets multiple (BLAD) modes of extract from Resistance not known. action: Swinglea glutinosa Plant extract from Resistance not known. extracts Melaleuca (previously F7) alternifolia (tea tree oil) plant oils (mixtures): eugenol, geraniol, thymol BM: T. atroviride nomenclature change from BM 02 Biologicals strain I-1237 Gliocladium catenulatum to with strain LU132 Clonostachys rosea multiple strain SC1 Resistance not known. modes of strain SKT-1 Bacillus amyloliquefaciens action: strain 77B reclassified from F6, Code 44 Microbial T. asperellum in 2020 (living strain T34 synonyms for Bacillus microbes, strain kd amyloliquefaciens are Bacillus extracts or T. harzianum subtilis and B. subtilis var. metabolites) strain T-22 amyloliquefaciens (previous T. virens taxonomic classification). strain G-41 C. rosea strain J1446 strain CR-7 C. minitans strain CON/M/91-08 H. uvarum strain BC18Y T. flavus strain SAY-Y-94-01 S. cerevisae strain LAS02 strain DDSF623 B. amyloliquefaciens strain QST713 strain FZB24 strain MBI600 strain D747 strain F727 strain AT-332 B. subtilis train AFS032321 strain Y1336 strain HAI-0404 PHC25279 G. cerinus strain BC18B P. chlororaphis strain AFS009 S. griseovirides strain K61 S. lydicus strain WYEC108

    TABLE-US-00011 APPENDIX 2 MODE OF ACTION CHEMICAL CLASSIFICATION ACTIVE Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Alloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Butroxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Clethodim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Cloproxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Cycloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Profoxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Sethoxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Tepraloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Tralkoxydim Carboxylase Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Clodinafop-propargyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Clofop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Cyhalofop-butyl Carboxylase (FOPs) Inhibition of Acetyl COA Aryloxyphenoxy-propionates Diclofop-methyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fenoxaprop-ethyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fenthiaprop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fluazifop-butyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Haloxyfop-methyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Isoxapyrifop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Metamifop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Quizalofop-ethyl Carboxylase (FOPs) Inhibition of Acetyl CoA Phenylpyrazoline Pinoxaden Carboxylase Inhibition of Acetolactate Pyrimidinyl benzoates Bispyribac-sodium Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyribenzoxim (prodrug of Synthase bispyribac) Inhibition of Acetolactate Pyrimidinyl benzoates Pyriftalid Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyriminobac-methyl Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyrithiobac-sodium Synthase Inhibition of Acetolactate Sulfonanilides Pyrimisulfan Synthase Inhibition of Acetolactate Sulfonanilides Triafamone Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Cloransulam-methyl Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Diclosulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Florasulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Flumetsulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Metosulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 2 Penoxsulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 2 Pyroxsulam Synthase Inhibition of Acetolactate Sulfonylureas Amidosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Azimsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Bensulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Chlorimuron-ethyl Synthase Inhibition of Acetolactate Sulfonylureas Chlorsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Cinosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Cyclosulfamuron Synthase Inhibition of Acetolactate Sulfonylureas Ethametsulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Ethoxysulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flazasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flucetosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flupyrsulfuron-methyl-Na Synthase Inhibition of Acetolactate Sulfonylureas Foramsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Halosulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Imazosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Iodosulfuron-methyl-Na Synthase Inhibition of Acetolactate Sulfonylureas Mesosulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Metazosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Metsulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Nicosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Orthosulfamuron Synthase Inhibition of Acetolactate Sulfonylureas Oxasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Primisulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Propyrisulfuron Synthase Inhibition of Acetolactate Sulfonylureas Prosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Pyrazosulfuron-ethyl Synthase Inhibition of Acetolactate Sulfonylureas Rimsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Sulfometuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Sulfosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Triasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Tribenuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Thifensulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Trifloxysulfuron-Na Synthase Inhibition of Acetolactate Sulfonylureas Triflusulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Tritosulfuron Synthase Inhibition of Acetolactate Imidazolinones Imazamethabenz-methyl Synthase Inhibition of Acetolactate Imidazolinones Imazamox Synthase Inhibition of Acetolactate Imidazolinones Imazapic Synthase Inhibition of Acetolactate Imidazolinones Imazapyr Synthase Inhibition of Acetolactate Imidazolinones Imazaquin Synthase Inhibition of Acetolactate Imidazolinones Imazethapyr Synthase Inhibition of Acetolactate Triazolinones Flucarbazone-Na Synthase Inhibition of Acetolactate Triazolinones Propoxycarbazone-Na Synthase Inhibition of Acetolactate Triazolinones Thiencarbazone-methyl Synthase Inhbition of Photosynthesis at Triazines Atraton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Atrazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Ametryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Aziprotryne = aziprotryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Chlorazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines CP 17029 PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Cyanazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Cyprazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Desmetryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Dimethametryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Dipropetryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Eglinazine-ethyl PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Ipazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Methoprotryne = methoprotryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines procyazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Proglinazine-ethyl PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Prometon PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Prometryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Propazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Sebuthylazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Secbumeton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Simetryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Simazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbumeton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbuthylazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbutryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Trietazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazolinone Amicarbazone PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Ethiozin PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Hexazinone PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Isomethiozin PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Metamitron PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Metribuzin PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Bromacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Isocil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Lenacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Terbacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Chlorprocarb PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Desmedipham PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Phenisopham PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Phenmedipham PSII - Serine 264 Binders Inhbition of Photosynthesis at Pyridazinone Chloridazon (=pyrazon) PSII - Serine 264 Binders Inhbition of Photosynthesis at Pyridazinone Brompyrazon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Benzthiazuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Bromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Buturon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chlorbromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chlorotoluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chloroxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Difenoxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Dimefuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Diuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Ethidimuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fenuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fluometuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fluothiuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Isoproturon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Isouron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Linuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metobenzuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metobromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Methabenzthiazuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metoxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Monolinuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Monuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Neburon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Parafluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Siduron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Tebuthiuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Thiazafluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Chloranocryl = dicryl PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Pentanochlor PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Propanil PSII - Serine 264 Binders Inhbition of Photosynthesis at Nitriles Bromofenoxim PSII - Histidine 215 Binders Inhbition of Photosynthesis at Nitriles Bromoxynil PSII - Histidine 215 Binders Inhbition of Photosynthesis at Nitriles Ioxynil PSII - Histidine 215 Binders Inhbition of Photosynthesis at Phenyl-pyridazines Pyridate PSII - Histidine 215 Binders Inhbition of Photosynthesis at Benzothiadiazinone Bentazon PSII - Histidine 215 Binders PS I Electron Diversion Pyridiniums Cyperquat PS I Electron Diversion Pyridiniums Diquat PS I Electron Diversion Pyridiniums Morfamquat PS I Electron Diversion Pyridiniums Paraquat Inhibition of Diphenyl ethers Lactofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Acifluorfen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Bifenox Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Chlornitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fomesafen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluorodifen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluoroglycofen-ethyl Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluoronitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Nitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Oxyfluorfen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Chlomethoxyfen Protoporphyrinogen Oxidase Inhibition of Phenylpyrazoles Pyraflufen-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-oxadiazolones Oxadiargyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-oxadiazolones Oxadiazon Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Azafenidin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Carfentrazone-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Sulfentrazone Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides (procide Fluthiacet-methyl Protoporphyrinogen Oxidase acitive form) Inhibition of N-Phenyl-imides Butafenacil Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Saflufenacil Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Pentoxazone Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Chlorphthalim Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Cinidon-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumiclorac-pentyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumioxazin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumipropyn Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Trifludimoxazin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Tiafenacil Protoporphyrinogen Oxidase Inhibition of Other Pyraclonil Protoporphyrinogen Oxidase Inhibition of Phytoene Phenyl ethers Beflubutamid Desaturase Inhibition of Phytoene Phenyl ethers Diflufenican Desaturase Inhibition of Phytoene Phenyl ethers Picolinafen Desaturase Inhibition of Phytoene N-Phenyl heterocycles Flurochloridone Desaturase Inhibition of Phytoene N-Phenyl heterocycles Norflurazon Desaturase Inhibition of Phytoene Diphenyl heterocycles Fluridone Desaturase Inhibition of Phytoene Diphenyl heterocycles Flurtamone Desaturase Inhibition of Hydroxyphenyl Triketones Mesotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Sulcotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Tembotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Tefuryltrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Bicyclopyrone Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Fenquinotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones (procide) Benzobicyclon Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Benzofenap Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Pyrasulfotole Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Topramezone Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Pyrazolynate Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Pyrazoxyfen Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Tolpyralate Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Isoxazoles Isoxaflutole Pyruvate Dioxygenase Inhibition of Homogentisate Phenoxypyridazine Cyclopyrimorate Solanesyltransferase Inhibition of Deoxy-D-Xyulose Isoxazolidinone Clomazone Phosphate Synthase Inhibition of Deoxy-D-Xyulose Isoxazolidinone Bixlozone Phosphate Synthase Inhibition of Enolpyruvyl Glycine Glyphosate Shikimate Phosphate Synthase Inhibition of Glutamine Phosphinic acids Glufosinate-ammonium Synthetase Inhibition of Glutamine Phosphinic acids Bialaphos/bilanafos Synthetase Inhibition of Dihydropteroate Carbamate Asulam Synthase Inhibition of Microtubule Dinitroanilines Benefin = benfluralin Assembly Inhibition of Microtubule Dinitroanilines Butralin Assembly Inhibition of Microtubule Dinitroanilines Dinitramine Assembly Inhibition of Microtubule Dinitroanilines Ethalfluralin Assembly Inhibition of Microtubule Dinitroanilines Fluchloralin Assembly Inhibition of Microtubule Dinitroanilines Isopropalin Assembly Inhibition of Microtubule Dinitroanilines Nitralin Assembly Inhibition of Microtubule Dinitroanilines Prodiamine Assembly Inhibition of Microtubule Dinitroanilines Profluralin Assembly Inhibition of Microtubule Dinitroanilines Oryzalin Assembly Inhibition of Microtubule Dinitroanilines Pendimethalin Assembly Inhibition of Microtubule Dinitroanilines Trifluralin Assembly Inhibition of Microtubule Pyridines Dithiopyr Assembly Inhibition of Microtubule Pyridines Thiazopyr Assembly Inhibition of Microtubule Phosphoroamidates Butamifos Assembly Inhibition of Microtubule Phosphoroamidates DMPA Assembly Inhibition of Microtubule Benzoic acid Chlorthal-dimethyl = DCPA Assembly Inhibition of Microtubule Benzamides Propyzamide = pronamide Assembly Inhibition of Microtubule Carbamates Barban Organization Inhibition of Microtubule Carbamates Carbetamide Organization Inhibition of Microtubule Carbamates Chlorbufam Organization Inhibition of Microtubule Carbamates Chlorpropham Organization Inhibition of Microtubule Carbamates Propham Organization Inhibition of Microtubule Carbamates Swep Organization Inhibition of Cellulose Triazolocarboxamide Flupoxam Synthesis Inhibition of Cellulose Benzamides Isoxaben Synthesis Inhibition of Cellulose Alkylazines Triaziflam Synthesis Inhibition of Cellulose Alkylazines Indaziflam Synthesis Inhibition of Cellulose Nitriles Dichlobenil Synthesis Inhibition of Cellulose Nitriles Chlorthiamid Synthesis Uncouplers Dinitrophenols Dinosam Uncouplers Dinitrophenols Dinoseb Uncouplers Dinitrophenols DNOC Uncouplers Dinitrophenols Dinoterb Uncouplers Dinitrophenols Etinofen Uncouplers Dinitrophenols Medinoterb Inhibition of Very Long-Chain Azolyl-carboxamides Cafenstrole Fatty Acid Synthesis Inhibition of Very Long-Chain Azolyl-carboxamides Fentrazamide Fatty Acid Synthesis Inhibition of Very Long-Chain Azolyl-carboxamides Ipfencarbazone Fatty Acid Synthesis Inhibition of Very Long-Chain -Thioacetamides Anilofos Fatty Acid Synthesis Inhibition of Very Long-Chain -Thioacetamides Piperophos Fatty Acid Synthesis Inhibition of Very Long-Chain Isoxazolines Pyroxasulfone Fatty Acid Synthesis Inhibition of Very Long-Chain Isoxazolines Fenoxasulfone Fatty Acid Synthesis Inhibition of Very Long-Chain Oxiranes Indanofan Fatty Acid Synthesis Inhibition of Very Long-Chain Oxiranes Tridiphane Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Acetochlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Alachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Allidochlor = CDAA Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Butachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Butenachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Delachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Diethatyl-ethyl Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Dimethachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Dimethenamid Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Metazachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Metolachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Pethoxamid Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Pretilachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Propachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Propisochlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Prynachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Thenylchlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Oxyacetamides Mefenacet Fatty Acid Synthesis Inhibition of Very Long-Chain -Oxyacetamides Flufenacet Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Butylate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Cycloate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Dimepiperate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates EPTC Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Esprocarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Molinate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Orbencarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Pebulate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Prosulfocarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Thiobencarb (=Benthiocarb) Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Tiocarbazil Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Tri-allate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Vernolate Fatty Acid Synthesis Inhibition of Very Long-Chain Benzofurans Benfuresate Fatty Acid Synthesis Inhibition of Very Long-Chain Benzofurans Ethofumesate Fatty Acid Synthesis Auxin Mimics Pyridine-carboxylates Picloram Auxin Mimics Pyridine-carboxylates Clopyralid Auxin Mimics Pyridine-carboxylates Aminopyralid Auxin Mimics Pyridine-carboxylates Halauxifen Auxin Mimics Pyridine-carboxylates Florpyrauxifen Auxin Mimics Pyridyloxy-carboxylates Triclopyr Auxin Mimics Pyridyloxy-carboxylates Fluroxypyr Auxin Mimics Phenoxy-carboxylates 2,4,5-T Auxin Mimics Phenoxy-carboxylates 2,4-D Auxin Mimics Phenoxy-carboxylates 2,4-DB Auxin Mimics Phenoxy-carboxylates Clomeprop Auxin Mimics Phenoxy-carboxylates Dichlorprop Auxin Mimics Phenoxy-carboxylates Fenoprop Auxin Mimics Phenoxy-carboxylates Mecoprop Auxin Mimics Phenoxy-carboxylates MCPA Auxin Mimics Phenoxy-carboxylates MCPB Auxin Mimics Benzoates Dicamba Auxin Mimics Benzoates Chloramben Auxin Mimics Benzoates TBA Auxin Mimics Quinoline-carboxylates Quinclorac Auxin Mimics Quinoline-carboxylates Quinmerac Auxin Mimics Pyrimidine-carboxylates Aminocyclopyrachlor Auxin Mimics Other Benazolin-ethyl Auxin Mimics Phenyl carboxylates Chlorfenac = fenac Auxin Mimics Phenyl carboxylates Chlorfenprop Auxin Transport Inhibitor Aryl-carboxylates Naptalam Auxin Transport Inhibitor Aryl-carboxylates Diflufenzopyr-sodium Inhibition of Fatty Acid Benzyl ether Cinmethylin Thioesterase Inhibition of Fatty Acid Benzyl ether Methiozolin Thioesterase Inhibition of Serine-Threonine Other Endothal Protein Phosphatase Inhibition of Solanesyl Diphenyl ether Aclonifen Diphosphate Synthase Inhibition of Lycopene Triazole Amitrole Cyclase Unknown Bromobutide Unknown Cumyluron Unknown Difenzoquat Unknown DSMA Unknown Dymron = Daimuron Unknown Etobenzanid Unknown Arylaminopropionic acid Flamprop-m Unknown Fosamine Unknown Methyldymron Unknown Monalide Unknown MSMA Unknown Oleic acid Unknown Oxaziclomefone Unknown Pelargonic acid Unknown Pyributicarb Unknown Quinoclamine Unknown Acetamides Diphenamid Unknown Acetamides Naproanilide Unknown Acetamides Napropamide Unknown Benzamide Tebutam Unknown Phosphorodithioate Bensulide Unknown Chlorocarbonic acids Dalapon Unknown Chlorocarbonic acids Flupropanate Unknown Chlorocarbonic acids TCA Unknown Trifluoromethanesulfonanilides Mefluidide Unknown Trifluoromethanesulfonanilides Perfluidone Unknown CAMA Unknown Cacodylic acid

    TABLE-US-00012 APPENDIX 3 Sub-group, class or Main Group and Primary exemplifying Active Site of Action Ingredient Active Ingredients 1 1A Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxim, Acetylcholinesterase (AChE) Carbamates Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, inhibitors Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Nerve action Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, {Strong evidence that action at this Pirimicarb, Propoxur, Thiodicarb, Thiofanox, protein is responsible for insecticidal Triazamate, Trimethacarb, XMC, Xylylcarb effects} 1B Acephate, Azamethiphos, Azinphos-ethyl, Azinphos- Organophosphates methyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/DDVP, Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio- phosphoryl) salicylate, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion- methyl, Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos- methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Trichlorfon, Vamidothion 2 2A Chlordane, Endosulfan GABA-gated chloride channel blockers Cyclodiene Nerve action Organochlorines {Strong evidence that action at this 2B Ethiprole, Fipronil protein is responsible for insecticidal Phenylpyrazoles effects} (Fiproles) 3 3A Acrinathrin, Allethrin, d-cis-trans Allethrin, d- trans Allethrin, Sodium channel modulators Pyrethroids Pyrethrins Bifenthrin, Bioallethrin, Bioallethrin S-cyclopentenyl isomer, Nerve action Bioresmethrin, Cycloprothrin, Cyfluthrin, beta- Cyfluthrin, {Strong evidence that action at this Cyhalothrin, lambda-Cyhalothrin, gamma-Cyhalothrin, protein is responsible for insecticidal Cypermethrin, alpha- Cypermethrin, beta-Cypermethrin, effects} theta- cypermethrin, zeta-Cypermethrin, Cyphenothrin, (1R)-trans- isomers], Deltamethrin, Empenthrin (EZ)- (1R)- isomers], Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate, Flumethrin, tau-Fluvalinate, Halfenprox, Imiprothrin, Kadethrin, Permethrin, Phenothrin [(1R)-trans- isomer], Prallethrin, Pyrethrins (pyrethrum), Resmethrin, Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomers], Tralomethrin, Transfluthrin, 3B DDT DDT Methoxychlor Methoxychlor 4 4A Acetamiprid, Clothianidin, Dinotefuran, Nicotinic acetylcholine receptor Neonicotinoids Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam, (nAChR) competitive modulators 4B Nicotine Nerve action Nicotine {Strong evidence that action at one or 4C Sulfoxaflor more of this class of protein is Sulfoximines responsible for insecticidal effects} 4D Flupyradifurone Butenolides 4E Triflumezopyrim Mesoionics 4F Flupyrimin Pyridylidenes 5 Spinosyns Spinetoram, Spinosad Nicotinic acetylcholine receptor (nAChR) allosteric modulators - Site I Nerve action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 6 Avermectins, Abamectin, Emamectin benzoate, Lepimectin, Milbemectin Glutamate-gated chloride Milbemycins channel (GluCl) allosteric modulators Nerve and muscle action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 7 7A Hydroprene, Kinoprene, Methoprene Juvenile hormone mimics Juvenile hormone Growth regulation analogues {Target protein responsible for biological 7B Fenoxycarb activity is unknown, or uncharacterized} Fenoxycarb 7C Pyriproxyfen Pyriproxyfen 8 * 8A Methyl bromide and other alkyl halides Miscellaneous non-specific (multi- Alkyl halides site) inhibitors 8B Chloropicrin Chloropicrin 8C Cryolite (Sodium aluminum fluoride), Sulfuryl fluoride Fluorides 8D Borax, Boric acid, Disodium octaborate, Sodium borate, Borates Sodium metaborate 8E Tartar emetic Tartar emetic 8F Dazomet, Metam Methyl isothiocyanate generators 9 9B Pymetrozine, Pyrifluquinazon Chordotonal organ TRPV Pyridine azomethine channel modulators Nerve action derivatives {Strong evidence that action at one or 9D Afidopyropen more of this class of proteins is Pyropenes responsible for insecticidal effects} 10 10A Clofentezine, Diflovidazin, Hexythiazox Mite growth inhibitors affecting Clofentezine Diflovidazin CHS1 Hexythiazox Growth regulation 10B Etoxazole {Strong evidence that action at one or Etoxazole more of this class of proteins is responsible for insecticidal effects} 11 11A Bacillus thuringiensis subsp. israelensis Bacillus Microbial disruptors of insect midgut Bacillus thuringiensis and thuringiensis subsp. aizawai Bacillus thuringiensis membranes the insecticidal proteins subsp. kurstaki Bacillus thuringiensis subsp. (Includes transgenic crops expressing they produce tenebrionis Bacillus thuringiensis toxins, however B.t. crop proteins: (* Please see footnote) Cry1Ab, Cry1Ac, specific guidance for resistance Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, management of transgenic crops is not Cry3Bb, Cry34Ab1/Cry35Ab1 based on rotation of modes of action) 11B Bacillus sphaericus Bacillus sphaericus 12 12A Diafenthiuron Inhibitors of mitochondrial ATP Diafenthiuron synthase 12B Azocyclotin, Cyhexatin, Fenbutatin oxide Energy metabolism Organotin miticides {Compounds affect the function of this 12C Propargite protein, but it is not clear that this is what Propargite leads to biological activity} 12D Tetradifon Tetradifon 13 * Pyrroles Dinitrophenols Chlorfenapyr DNOC Uncouplers of oxidative Sulfluramid Sulfluramid phosphorylation via disruption of the proton gradient Energy metabolism 14 Nereistoxin analogues Bensultap, Cartap hydrochloride, Thiocyclam, Nicotinic acetylcholine receptor Thiosultap-sodium (nAChR) channel blockers Nerve action {Compounds affect the function of this protein, but it is not clear that this is what leads to biological activity} 15 Benzoylureas Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, Inhibitors of chitin biosynthesis Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron, affecting CHS1 Noviflumuron, Teflubenzuron, Triflumuron Growth regulation {Strong evidence that action at one or more of this class of proteins is responsible for insecticidal effects} 16 Buprofezin Buprofezin Inhibitors of chitin biosynthesis, type 1 Growth regulation {Target protein responsible for biological activity is unknown, or uncharacterized} 17 Cyromazine Cyromazine Moulting disruptors, Dipteran Growth regulation {Target protein responsible for biological activity is unknown, or uncharacterized} 18 Diacylhydrazines Chromafenozide, Halofenozide, Methoxyfenozide, Ecdysone receptor agonists Tebufenozide Growth regulation {Strong evidence that action at this protein is responsible for insecticidal effects} 19 Amitraz Amitraz Octopamine receptor agonists Nerve action {Good evidence that action at one or more of this class of protein is responsible for insecticidal effects} 20 20A Hydramethylnon Mitochondrial complex III electron Hydramethylnon transport inhibitors - Qo site 20B Acequinocyl Energy metabolism Acequinocyl {Good evidence that action at this 20C Fluacrypyrim protein complex is responsible for Fluacrypyrim insecticidal effects} 20D Bifenazate Bifenazate 21 21A Fenazaquin, Fenpyroximate, Pyridaben, Pyrimidifen, Mitochondrial complex I electron METI acaricides and Tebufenpyrad, Tolfenpyrad transport inhibitors insecticides Energy metabolism 21B Rotenone (Derris) {Good evidence that action at this Rotenone protein complex is responsible for insecticidal effects} 22 22A Indoxacarb Voltage-dependent sodium Oxadiazines channel blockers 22B Metaflumizone Nerve action Semicarbazones {Good evidence that action at this protein complex is responsible for insecticidal effects} 23 Tetronic and Tetramic acid Spirodiclofen, Spiromesifen, Spiropidion, Spirotetramat Inhibitors of acetyl CoA carboxylase derivatives Lipid synthesis, growth regulation {Good evidence that action at this protein is responsible for insecticidal effects} 24 24A Aluminium phosphide, Calcium phosphide, Phosphine, Zinc Mitochondrial complex IV electron Phosphides phosphide transport inhibitors 24B Calcium cyanide, Potassium cyanide, Sodium cyanide Energy metabolism Cyanides {Good evidence that action at this protein complex is responsible for insecticidal effects} 25 25A Cyenopyrafen, Cyflumetofen Mitochondrial complex II electron Beta-ketonitrile transport inhibitors derivatives Energy metabolism 25B Pyflubumide {Good evidence that action at this Carboxanilides protein complex is responsible for insecticidal effects} 28 Diamides Chlorantraniliprole, Cyantraniliprole, Cyclaniliprole Ryanodine receptor Flubendiamide, Tetraniliprole modulators Nerve and muscle action {Strong evidence that action at this protein complex is responsible for insecticidal effects} 29 Flonicamid Flonicamid Chordotonal organ modulators - undefined target site Nerve action (Modulation of chordotonal organ function has been clearly demonstrated, but the specific target protein(s) responsible for biological activity are distinct from Group 9 and remain undefined) 30 Meta-diamides Isoxazolines Broflanilide GABA-gated chloride channel allosteric Fluxametamide, Isocyloseram modulators Nerve action {Strong evidence that action at this protein complex is responsible for insecticidal effects} 31 Granuloviruses (GVs) Cydia pomonella GV Baculoviruses Thaumatotibia leucotreta GV Host-specific occluded Nucleopolyhedroviruse s Anticarsia gemmatalis MNPV pathogenic viruses (NPVs) Helicoverpa armigera NPV (Midgut epithelial columnar cell membrane target site - undefined) 32 GS-omega/kappa GS-omega/kappa HXTX-Hv1a peptide Nicotinic Acetylcholine Receptor HXTX-Hv1a peptide (nAChR) Allosteric Modulators - Site II Nerve action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 33 Acynonapyr Acynonapyr Calcium-activated potassium channel (KCa2) modulators Nerve action {Strong evidence that action at this protein is responsible for insecticidal effects} 34 Flometoquin Flometoquin Mitochondrial complex III electron transport inhibitors - Qi site Energy metabolism {Modulation of this protein complex has been clearly demonstrated and the specific target site responsible for biological activity is distinct from Group 20} UN* Azadirachtin Azadirachtin Compounds of unknown or uncertain Benzoximate Benzoximate MoA Benzpyrimoxan Benzpyrimoxan {Target protein responsible for biological Bromopropylate Bromopropylate activity is unknown, or uncharacterized} Chinomethionat Chinomethionat Dicofol Dicofol Lime sulfur Lime sulfur Mancozeb Mancozeb Pyridalyl Pyridalyl Sulfur Sulfur UNB* Burkholderia spp Bacterial agents (non-Bt) of unknown or Wolbachia pipientis (Zap) uncertain MoA {Target protein responsible for biological activity is unknown or uncharacterized} UNE* Chenopodium ambrosioides near ambrosioides Botanical essence including extract synthetic, extracts and unrefined Fatty acid monoesters with glycerol or propanediol Neem oil oils with unknown or uncertain MoA {Target protein responsible for biological activity is unknown, or uncharacterized} UNF* Beauveria bassiana strains Fungal agents of unknown or uncertain Metarhizium anisopliae strain F52 MoA Paecilomyces fumosoroseus Apopka strain 97 {Target protein responsible for biological activity is unknown, or uncharacterized} UNM* Diatomaceous earth Non-specific mechanical and physical Mineral oil disruptors {Target protein responsible for biological activity is unknown, or uncharacterized}

    [0472] In view of the many possible embodiments to which the principles of the disclosed invention may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. Rather, the scope of the invention is defined by the following claims. We therefore claim as our invention all that comes within the scope and spirit of these claims.